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Abstract: Anxiety sensitivity, defined as the fear of anxiety-related sensations and 
their consequences (Reiss & McNally, 1985), has been consistently shown to be 
associated with risk for anxiety psychopathology as well as other mental health problems. 
The primary objective of the present secondary prevention trial sought to examine 
strategies to reduce anxiety sensitivity among persons with elevated anxiety sensitivity by 
testing the singular and combined efficacy of two commonly used strategies in multi-
component interventions for reducing anxiety sensitivity: (a) anxiety psychoeducation 
emphasizing the benign nature of stress and (b) interoceptive exposure (i.e. repeated 
inhalations of 35% CO2 gas mixture).  
To provide a stringent control for non-specific effects associated with anxiety 
psychoeducation and interoceptive exposure with CO2, two control strategies were 
included in the study design: general health and nutrition education and repeated 
inhalations of regular room air. Utilizing a 2X2 design, participants were randomly 
assigned to receive an education component and intervention sessions consisting of one 
of two gas mixtures. 
 vi 
The current study did not support the relative efficacy of hypothesized active 
intervention strategies. Rather, all conditions led to significant reductions in anxiety 
sensitivity. In addition, within-condition effect sizes for conditions in the present study 
were comparable to effect sizes of active interventions that were efficacious in previous 
research.  
Findings from the present study support that anxiety sensitivity is malleable 
following brief, cost-efficient interventions and these reductions are maintained over a 
one-month follow-up period. Data from the present study suggest that in the presence of 
stringent control conditions, hypothesized active intervention strategies provided little 
additional benefit. 
The present study has implications for methodological considerations for future 
secondary prevention trials for the reduction of anxiety sensitivity. The absence of 
stringent control groups might lead to premature conclusions that reductions in anxiety 
sensitivity are due to the specific effects of active interventions. Further research is 
needed to elucidate specific effects of intervention strategies for the reduction of anxiety 
sensitivity in at risk populations in order to refine secondary prevention interventions 
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Chapter 1:  Background 
ANXIETY SENSITIVITY 
Anxiety sensitivity is defined as the “fear of anxiety-related sensations based on 
their harmful consequences” (Reiss and McNally, 1985) and was originally 
conceptualized as a trait-like dispositional variable that describes a “fear of fear.” 
Anxiety sensitivity was first introduced in the context of expectancy theory, which 
proposed that fear and anxiety in a given situation developed from the interaction of 
dispositional sensitivities and expectations about the feared situation. The theory posits 
that all common fears (e.g., fear of public speaking or fear of heights) are derived from 
three fundamental fears: anxiety sensitivity, fear of illness/injury and death, and fear of 
negative social evaluation. The interaction of these fundamental fears with expectancy 
beliefs about the outcomes of a given situation predicts the likelihood of fear and 
avoidance in that situation. Therefore, the theoretical predictions of expectancy theory 
delineate anxiety sensitivity as a central variable in the development and expression of 
anxiety. 
MEASURING ANXIETY SENSITIVITY  
 Anxiety sensitivity was first measured by the Anxiety sensitivity index (ASI), a 
16-item questionnaire assessing fears of anxiety-related sensations and beliefs about their 
harmful consequences (Reiss, Peterson, Gursky, & McNally, 1986). Although anxiety 
sensitivity was originally conceptualized as unidimensional, factor analytic studies on the 
original ASI suggested that anxiety sensitivity might be better conceptualized as 
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multidimensional (Telch, Shermis, & Lucas, 1989; see Zinbarg, Mohlman, & Hong, 
1999). Of the factor analytic studies, the most common factor solution includes three 
factors: physical concerns, social concerns, and cognitive concerns (see Zinbarg et al., 
1999). Although the hierarchical structure of anxiety sensitivity does not support the 
original conceptualization of anxiety sensitivity as a fundamental fear, the lower-order 
factors provide additional utility when examining the relationship between anxiety 
sensitivity and psychological outcomes. 
 Because of inconsistent results in factor solutions and criticisms of the small 
number of items comprising certain subscales, Taylor and Cox (1998b) created the ASI-
revised (ASI-R): a 36-item questionnaire aimed to more comprehensively measure the 
lower-order factors of anxiety sensitivity. The scale was designed to measure fears of 
cardiovascular, respiratory, gastrointestinal, publicly observable, dissociative and 
neurological, and cognitive dyscontrol concerns. Factor analytic studies based on the 
ASI-R have not replicated the six factors that were intended in the creation of the scale 
and have yielded inconsistent results (Taylor & Cox., 1998a; Zvolensky et al., 2003). 
 The Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007) was developed to 
measure the three most widely replicated factors: physical, social, and cognitive 
concerns. The study resulted in an 18-item scale with a stable three-factor solution that 
was replicated across gender and among individuals from various countries as well as 
clinical and nonclinical populations. Most of the published studies examining anxiety 
sensitivity in adults to date have employed the original ASI scale. 
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 The Childhood Anxiety Sensitivity Index (CASI) was developed to measure 
anxiety sensitivity in children and adolescents (Silverman,  Fliesig, Rabian, & Peterson., 
1991). It is an 18-item scale that is similar to the original ASI but modified to be more 
age-appropriate. Similar to the structure of anxiety sensitivity in the adult literature, there 
is evidence that the CASI is hierarchical in nature, however there has been debate 
regarding the number of factors that best represent anxiety sensitivity (Chorpita & 
Daleiden, 2000; Silverman, Ginsburg, & Goedhart, 1999; Van Widenfelt, Siebelink, 
Goedhart, & Teffers, 2002). 
Although the expectancy theory assumed a dimensional latent structure for 
anxiety sensitivity, additional empirical research suggests that the latent structure of 
anxiety might be taxonic (i.e. discrete latent classes). Studies using various versions of 
the anxiety sensitivity index have confirmed the taxonicity of anxiety sensitivity across 
gender and age group (Bernstein, Zvolensky, Feldner, Lewis, &Leen-Feldner, 2005; 
Schmidt, Buckner, & Keough, 2007). In addition, a cross-cultural supported a taxonic 
structure of anxiety sensitivity among samples from France, Mexico, Spain, the 
Netherlands and the US and Canada (Bernstein et al., 2006). 
Additional studies have shown that a taxonic measurement of anxiety sensitivity 
demonstrates incremental validity in predicting clinically-relevant outcomes, such as 
panic symptoms, PTSD symptoms, and fear response to biological challenges (Richey, 
Schmidt, Hoffman, & Timpano, 2010). In addition to the utility of anxiety sensitivity 
taxons, research suggests that within-taxon variability provides additional utility in 
predicting clinically relevant outcomes (Bernstein et al., 2007; Bernstein, Zvolensky, 
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Marshall, & Schmidt, 2009; Zvolensky et al., 2007). Although most of the taxometric 
investigations have supported the taxonic latent class structure of anxiety sensitivity, the 
majority of research conducted thus far examining anxiety sensitivity has assumed a 
dimensional latent class structure. 
ANXIETY SENSITIVITY AND MENTAL HEALTH DISORDERS 
Anxiety Sensitivity and Anxiety Disorders 
Consistent with expectancy theory, researchers have demonstrated a positive 
association between anxiety sensitivity and anxiety disorders. Compared with nonclinical 
individuals, individuals diagnosed with anxiety disorders display elevated anxiety 
sensitivity. In addition, prospective studies have found that anxiety sensitivity increases 
the likelihood of developing an anxiety disorder (Schmidt, Zvolensky, & Maner, 2006; 
Schmidt & Zvolensky, 2007). 
Among the anxiety disorders, anxiety sensitivity is differentially elevated. 
Individuals with panic disorder and post-traumatic stress disorder (PTSD) display the 
highest levels of anxiety sensitivity, while individuals with specific phobias have not 
exhibited significant elevations in anxiety sensitivity as compared to the normal 
population (see Taylor et al., 1999). There is also evidence that the lower order factors of 
anxiety sensitivity are differentially elevated among populations with different anxiety 
disorders (Deacon & Abramowitz, 2006; McWilliams, Becker, Margraf, Clara & 
Vriends, 2007; Rector, Szacun-Shmizu, & Leybman, 2007). 
Anxiety Sensitivity and Panic Disorder 
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Although the expectancy model purports that anxiety sensitivity predisposes 
individuals to developing various types of fears, the majority of research in the area of 
anxiety sensitivity and anxiety disorders has been conducted in relation to panic disorder. 
Patients with panic disorder have been shown to display the highest anxiety sensitivity 
among individuals with anxiety disorders (see Cox, Borger, Enns, & Freeman, 1999; 
Taylor, Koch, & McNally, 1992). Specifically, the physical concerns (Deacon & 
Abramowitz, 2006) and psychological concerns subscales (McWilliams, Becker, 
Margraf, Vriends & Clara, 2007) have been found to be most strongly associated with 
panic disorder status.  
Additional research has shown that high anxiety sensitivity may be a premorbid 
risk factor for panicogenic response in the nonclinical population. For example, 
prospective studies have demonstrated that high anxiety sensitivity predicts the onset of 
spontaneous panic attacks and panic symptoms during stressful periods (Schmidt, Lerew, 
& Jackson, 1997, 1999) as well as over time (Maller & Reiss, 1992; Plehn & Peterson, 
2002; Schmidt, Zvolensky & Maner, 2006). In contrast, Schmidt, Lerew, and Joiner 
(2000) found that the experience of spontaneous panic attacks during a stressful period 
adversely affected anxiety sensitivity, suggesting that distress might affect anxiety 
sensitivity as well. 
Anxiety sensitivity is also associated with heightened fear response to fear 
provocation challenges. Experimental researchers interested in the phenomenon of 
anxiety  have examined fear response to biological challenges that are intended to 
provoke fear and panic, such as ingestion of high doses of caffeine or inhalation of a 
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carbon dioxide gas mixture (Carter, Suchday, & Gore, 2001; Telch, Silverman, & 
Schmidt, 1996; Zvolensky et al., 1997; 1999). Physical concerns, specifically suffocation 
fears, have been implicated as the strongest predictors of fear response to biological 
challenges (Beck, & Davila, 2007; Carter et al., 2001; Eke and McNally, 1996; ; Grant, 
Zinbarg et al., 2001; McNally and Eke, 1996; Shipherd, Beck, & Ohtake, 2001; Tull, 
2006; Zvolensky, Feldner, Eifert, & Stewart, 2001).  
In addition to the research examining anxiety sensitivity as a premorbid risk factor 
for the development of panic and panic disorder, a small group of studies have 
demonstrated a pathoplastic relationship between anxiety sensitivity and panic disorder. 
Pathoplasty models suggest that a variable might modify the expression or course of a 
disorder. In laboratory experiments conducted with patients with panic disorder, anxiety 
sensitivity predicted fear response to voluntary hyperventilation (Carter et al., 2001; 
Rapee & Medoro, 1994 ) as well as inhalation of 20% CO2 enriched air. (Eifert, 
Zvolensky, & Sorell, 1999). In addition, Schmidt and Bates (2003) found that anxiety 
sensitivity predicted symptom presentation among patients with panic disorder. 
Anxiety Sensitivity and PTSD 
Because patients with PTSD have displayed similar elevations in anxiety 
sensitivity as patients with panic disorder (Taylor et al., 1992), there has been growing 
interest in examining the relationship between anxiety sensitivity and PTSD.  
Several studies have demonstrated a positive association between anxiety 
sensitivity and PTSD among trauma-exposed individuals, (Bernstein et al., 2005; 
Fedoroff, Taylor, Asmundson, & Koch, 2000; Hensley & Varela, 2008; Kilic, Kilic, & 
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Yilmaz, 2008) especially for women (Feldner, Zvolensky, Schmidt, & Smith, 2008). For 
example, Asmundson and Stapleton (2008) found that police officers who endorsed 
significant PTSD symptoms reported greater anxiety sensitivity than those who did not. 
Similarly, women with current PTSD exhibited higher anxiety sensitivity than women 
who did not develop PTSD among a sample of women with history of intimate partner 
violence (Lang, Kennedy, & Stein, 2002).  
Additional research has shown that anxiety sensitivity is associated with traumatic 
stress reactions among nonclinical individuals. In a prospective study, baseline anxiety 
sensitivity predicted symptoms of PTSD among nonclinical individuals over an 18-month 
naturalistic follow-up period (Feldner et al., 2008). In addition, baseline anxiety 
sensitivity scores predicted subsequent PTSD symptoms among women two weeks after 
giving birth (Keogh, Ayers, & Francis, 2002). 
Examinations of the lower order factors of anxiety sensitivity have yielded 
inconsistent results. Two studies suggested that the physical and psychological concerns 
subscales of anxiety sensitivity were significant predictors of PTSD symptoms (Lang et 
al., 2002; Leen-Feldner, Feldner, Reardon, Babson, & Dixon, 2008); but Collimore, 
McCabe, Carleton, & Asmundson (2008) found that the physical subscale was the only 
lower order subscale to predict symptoms of PTSD among nonclinical individuals and 
Feldner, Lewis, Leen-Feldner, Schnurr, & Zvolensky (2006) found that the psychological 
subscale was the only significant lower order predictor of PTSD symptoms among 
trauma-exposed young adults. Finally, Keogh et al. (2002) demonstrated that the anxiety 
sensitivity physical and social concerns but not psychological concerns subscales were 
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associated with PTSD symptoms among women who had given birth in the last two 
weeks. Although the specific subscales associated with PTSD remain unclear, the 
inconsistent results may be a function of differences among the studies in methodological 
designs and examined populations. 
Consistent with a diathesis-stress model of PTSD, Bernstein, Zvolensky, Feldner, 
Lewis, and Leen-Feldner (2005) found that anxiety sensitivity interacted with trauma 
exposure to predict PTSD symptoms in nonclinical individuals. Furthermore, Feldner et 
al. (2006) demonstrated that anxiety sensitivity interacted with degree of trauma exposure 
such that trauma exposure was associated with PTSD symptoms in individuals with high 
anxiety sensitivity but not for those with low anxiety sensitivity. Finally, Lang, et al. 
(2002) demonstrated that traumatic experiences might subsequently amplify anxiety 
sensitivity; the study found that women exposed to intimate partner violence without 
subsequently developing PTSD displayed significantly higher anxiety sensitivity than 
non-exposed controls.  
Anxiety Sensitivity and Other Anxiety Disorders 
Although expectancy theory predicts that anxiety sensitivity might predict the 
development of various fears, there have been few studies examining the specific 
relationships between anxiety sensitivity and obsessive-compulsive disorder (OCD), 
generalized anxiety disorder (GAD), social phobia, or specific phobias. These studies 
have shown that anxiety sensitivity is elevated among individuals with social phobia, 
GAD, and OCD but have not revealed a positive association between anxiety sensitivity 
and specific phobias (see Cox, Borger, & Enns 1999). 
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The lower-order factors of anxiety sensitivity are differentially associated with 
each of the anxiety disorders; as predicted, social concerns are most strongly associated 
with social phobia (Deacon & Abramowitz, 2006; McWilliams, Becker, Margraf, Clara 
& Vriends, 2007; Rector et al., 2007). Psychological concerns are strongly associated 
with GAD (Rector et al., 2007), and physical concerns are associated with OCD (Deacon 
& Abramowitz, 2006).  
Anxiety Sensitivity and Depression 
Because of the high comorbidity rates between anxiety disorders and depression, 
there has been a growing literature demonstrating a positive association between anxiety 
sensitivity and depression as well. For example, Otto, Pollack, Fava, & Rosenbaum 
(1995) found that depressed patients reported higher anxiety sensitivity than normal 
controls and that the mean of anxiety sensitivity for the depressed group was comparable 
to the norms published for anxiety disorders. Taylor, Koch, Woody and McLean (1996) 
found similar means for depressed patients, and examinations of the lower order factors 
indicated that the cognitive concerns subscale was most strongly related to depression. 
On the other hand, McWilliams, Becker, Margraf, Clara & Vriends (2007) found that the 
physical and social concerns subscales were elevated among individuals with depression. 
In a longitudinal investigation, Cox, Enns, Freeman and Walker (2001) sought to 
clarify the relationship between anxiety sensitivity and depression; the study examined 
changes in anxiety sensitivity among individuals who were initially depressed and who 
recovered from major depression over a 1-year naturalistic time period. The results 
suggested that anxiety sensitivity improved only modestly over the time period during 
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which the participants were recovering from major depression.  Although this does not 
rule out the possibility that anxiety sensitivity might have increased as a result of the 
disorder, it suggests that anxiety sensitivity is not a concomitant of depression. Therefore, 
additional research is needed in order to establish anxiety sensitivity as a pre-existing 
vulnerability factor for depression. 
Anxiety Sensitivity and Chronic Pain 
Cognitive behavioral models of chronic pain have proposed that fear and 
avoidance of pain contribute to the development and maintenance of pain (Asmundson, 
Norton, & Norton, 1999; Norton & Asmundson, 2003). Thus, although chronic pain is 
not itself considered a fear; there is relevance in examining the role of anxiety sensitivity 
in the area of pain.  
Experimental studies utilizing pain provocation tasks provide evidence that 
anxiety sensitivity influences the experience of pain. Among nonclinical individuals, high 
anxiety sensitivity is associated with less tolerance of pain. In addition, nonclinical 
individuals high in anxiety sensitivity reported earlier detections of harmless electrical 
stimulations, suggesting that they have greater “interoceptive sensitivity” (Esteve & 
Camacho, 2008). Similarly, anxiety sensitivity was associated with earlier detections of 
pain during cold pressor task among nonclinical individuals (i.e. placing hand in a bath of 
cold water; Keogh & Cochrane, 2002) as well as individuals with panic disorder 
(Schmidt & Cook, 1999) and chronic pain (Greenberg & Burns, 2003). 
Additional studies have shown that gender moderates the association between 
anxiety sensitivity and pain during the cold pressor tasks. Studies have suggested that 
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anxiety sensitivity was associated with subjective pain only in women (Keogh, Barlow, 
Mounce, & Bond, 2006; Keogh & Birkby, 1999) or that the association was stronger with 
women (Thompson, Keogh, French, & Davis, 2008). One study found that pain tolerance 
was negatively associated with anxiety sensitivity in men but not in women (Keogh et al., 
2006). 
Most research with individuals with chronic pain indicates that anxiety sensitivity 
is not associated with severity of pain but with the negative effects resulting from pain. 
For example, chronic back pain patients with high anxiety sensitivity exhibited greater 
negative affect, greater emotional response to pain, and greater fear of pain than patients 
with low anxiety sensitivity (Asmundson & Norton, 1995). Zvolensky, Goodie, McNeil, 
Sperry, and Sorrell (2001) found similar associations between anxiety sensitivity and fear 
of pain within a heterogeneous chronic pain population.  
Several studies have examined cognitive behavioral models of pain and explored 
potential mechanisms of the association between anxiety sensitivity and pain. For 
example, Esteve and Camacho (2008) found that anxiety sensitivity was associated with 
more catastrophizing thoughts about pain during a pain provocation task; Keogh and 
Cochrane (2002) demonstrated that the association between anxiety sensitivity and 
subjective pain was mediated by negative interpretive bias. Using structural equation 
modeling, Asmundson and Taylor (1996) demonstrated that anxiety sensitivity was 
significantly associated with fear of pain after controlling for the severity of pain in 
patients with chronic musculoskeletal pain. In addition, they found that anxiety 
sensitivity predicted escape and avoidance behavior and that this association was 
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mediated by the fear of pain. Similarly, Norton and Asmundson (1995) found an indirect 
relationship of anxiety sensitivity and avoidance/escape behavior via fear of pain among 
individuals with recurrent headaches. Asmundson and Taylor (1996) discussed that this 
type of model is consistent with the theoretical predictions of expectancy theory in that 
common fears, such as fear of pain, can be reduced to more fundamental fears. 
Anxiety Sensitivity and Substance Use 
Because individuals with high anxiety sensitivity find anxiety-related sensations 
highly aversive, McNally (1996) proposed that individuals high in this trait would be 
motivated to use substances with anxiolytic properties as a method to avoid experiencing 
anxiety.  
Among nonclinical populations, the association between anxiety sensitivity and 
substance use is not clear. Studies have demonstrated an association between anxiety 
sensitivity and problematic drinking (Koven, Heller, & Miller, 2005; Stewart et al. 2002) 
as well as anxiety sensitivity and marijuana use (Zvolensky et al., 2009), but Novak, 
Burgess, Clark, Zvolensky and Brown (2003) found no association between anxiety 
sensitivity and drinking behavior. In addition, Wagner (2001) found that anxiety 
sensitivity was negatively correlated with substance abuse among undergraduate students. 
Research examining motives, expectancies and affect among nonclinical 
populations has further established anxiety sensitivity as an important variable in 
predicting substance use among nonclinical individuals. Anxiety sensitivity was 
associated with coping-related motives (Novak et al., 2003) and conformity-related 
motives to use alcohol (Stewart & Zeitlin, 1995) as well as marijuana (Zvolensky et al., 
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2009). Anxiety sensitivity was also associated with negative reinforcement expectancies 
among daily smokers (Johnson et al., 2008). In addition, anxiety sensitivity was 
associated with drinking frequency in negatively reinforcing situations (Samoluk & 
Stewart, 1998). In a laboratory experiment, alcohol consumption reduced state anxiety 
only among individuals with anxiety sensitivity (Zack, Poulos, Aramakis, Khamba, & 
Macleod, 2007). 
O‟Connor, Farrow, & Colder (2008) demonstrated that a 3-way interaction of 
anxiety sensitivity, expectancies, and gender predicted drinking behavior. They found 
high anxiety sensitivity was associated with heavy drinking when tension reduction 
expectancies were high among men, and high anxiety sensitivity was associated with low 
levels of drinking when cognitive and behavioral impairment expectancies were high 
among women. They suggested that this interaction potentially explains some of the 
inconsistencies in findings related to the association between anxiety sensitivity and 
substance use in past research. Taken together, these studies suggest that individuals with 
high anxiety sensitivity may be motivated to use substances in anxiety-provoking 
situations when they have expectations that using substances will reduce distress. This is 
in line with McNally‟s prediction (1996) that anxiety sensitivity would motivate 
individuals to use substances with anxiolytic properties in order to tolerate anxiety-
related sensations. 
Cognitive-behavioral models of substance use suggest that if substance use is 
reinforcing, it could ultimately lead to problematic substance use. Anxiety sensitivity has 
been shown to be elevated among individuals diagnosed with alcohol abuse disorders (as 
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cited by Stewart, Zvolensky, & Eifert, 2002), and a prospective study indicated that 
anxiety sensitivity predicted subsequent development of alcohol abuse disorders among 
university students (Schmidt, Buckner & Keough, 2007). In addition, anxiety sensitivity 
has been shown to be associated with frequency of substance use among individuals with 
substance use disorders. 
Research has demonstrated that anxiety sensitivity might be associated with using 
substances as a means to reduce negative affect among individuals with substance use as 
well. For example, anxiety sensitivity predicts preference for depressants among 
individuals with substance use disorders (DeHaas et al., 2001; 2002; Norton et al. 1997), 
although there was no association between anxiety sensitivity and drug of choice among 
veterans in an inpatient program for substance use (Forsyth, Parker, & Finlay, 2003). In 
addition, anxiety sensitivity was related to frequency of drinking in negative situations 
among women in treatment for alcohol problems, and this association was strongest when 
examining the physical concerns and cognitive concerns subscales (Reyno, Stewart, 
Brown, Wiens, & Horvath, 2006). Furthermore, Kushner, Thuras, Abrams, Stritar, and 
Brekke (2001) found that the relation between anxiety sensitivity and coping-related 
drinking motives for individuals with alcohol problems was mediated by anxiety. 
Contrary to predictions, however, the association between anxiety sensitivity and 
substance use was not stronger for individuals with comorbid anxiety disorders. (DeHaas, 
Calamari, Bair, & Martin 2001; DeHaas, Calamari, & Bair, 2002). Therefore, anxiety 
sensitivity might serve as a risk factor for motivating substance use among individuals 
with substance use disorders. 
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Anxiety sensitivity might also decrease likelihood of successfully stopping 
substance use. For example, anxiety sensitivity was associated with perceived barriers to 
quitting smoking, such as “being addicted to cigarettes” or “fear of failing to quit.” In 
addition, the physical concerns subscale of anxiety sensitivity was related to early 
smoking relapse (Gonzalez, Zvolensky, Vujanovic, Marshall, & Leyro, 2008). Finally, 
anxiety sensitivity predicted treatment dropout among heroin users who were 
participating in a treatment program (Lejuez et al., 2008). 
Cost of Mental Health Disorders 
 The extant literature supports theoretical predictions that anxiety sensitivity is a 
premorbid vulnerability factor for the development of anxiety problems, and there is also 
evidence that anxiety sensitivity may be an important contributor to the expression of 
these mental health disorders as well. Additional research has shown that anxiety 
sensitivity is associated with other mental health disorders including depression, chronic 
pain, and substance use disorders. 
The mental disorders that have been found to be associated with anxiety 
sensitivity are highly prevalent. In the National Comorbidity Survey-replication study, 
anxiety disorders were the most prevalent class of Axis I disorders (28.8%), and mood 
(20.8%) and substance use disorders (14.6%) were also highly prevalent (Kessler, Chiu, 
Demler, & Walters, 2005). The lifetime prevalence of any Axis I disorder was 46.4%. 
With regard to chronic pain, an international World Health Organization study reported 
that 22% of individuals in primary care centers reported persistent pain (Gureje, Von 
Korff, Simon, & Gater, 1998). 
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In addition to the diminished quality of life for individuals suffering from these 
disorders, there are also considerable costs to society. Based on data from the original 
National Comorbidity Survey, Greenberg et al. (1999) estimated the annual cost of 
anxiety disorders was 42.3 billion dollars in the United States; similarly, Greenberg et al. 
(2003) estimated the annual cost of depression was 83.1 billion dollars based on data 
from the National Comorbidity Survey-revised. These estimates were based on direct 
treatment costs, mortality costs associated with suicide, and indirect workplace costs. For 
chronic pain, the costs associated with loss of productivity in the U.S. workforce alone 
were estimated to be $61.2 million a year based on data from 2003 (Stewart, Ricci, Chee, 
Morganstein, & Lipton, 2003). In a report developed for The Office of National Drug 
Control Policy (ONDCP), the societal cost of drug abuse in the United States was $143.4 
billion in 1998. The majority of these costs were associated with productivity losses, 
particularly those related to incarceration, crime, illness, and premature death (Office of 
National Drug Control Policy, 2001). Because many of the previously mentioned 
estimates were based on data from the 1990s, it is likely that the current societal costs of 
the mental disorders are greater. 
The association of anxiety sensitivity with multiple mental health problems that 
are prevalent and costly implies that it is a significant variable that should be targeted in 
prevention efforts. Research evidencing that it is a premorbid risk factor for the 
development of mental health disorders as well as its association with the expression of 
mental health disorders suggests that examining strategies to effectively reduce anxiety 
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sensitivity would significantly contribute to secondary and tertiary prevention efforts for 
multiple mental health problems. 
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Chapter 2: Anxiety Sensitivity Reduction 
CLINICAL POPULATIONS  
Anxiety sensitivity has been shown to be malleable with CBT (see Smits et al., 
2008) as well as pharmacotherapy (Olatunji et al., 2008; Otto, Pollack, Fava, & Uccello, 
1995; Simon et al., 2004) among patients with clinical disorders. In a meta-analysis, 
Smits et al. (2008) examined the efficacy for reducing anxiety sensitivity with CBT and 
found a large controlled effect size (Hedges‟ g = 1.40) for the reduction of anxiety 
sensitivity among populations with clinical disorders. Of 16 studies conducted examining 
anxiety sensitivity reduction, most studies included patients with panic disorder; patients 
with social phobia, claustrophobia and tinnitus were also included.  
INTERVENTION STRATEGIES FOR NONCLINICAL POPULATIONS 
Anxiety sensitivity has been shown to be modifiable following interventions 
conducted among nonclinical populations as well. Smits et al. (2008) found a moderate 
effect size for the efficacy of CBT interventions in reducing anxiety sensitivity (Hedges‟ 
g = .74) in a meta-analysis of eight studies conducted with nonclinical individuals with 
high anxiety sensitivity. 
CBT interventions 
 Prevention research has examined the efficacy of interventions targeting anxiety 
sensitivity reduction among nonclinical populations with high anxiety sensitivity. 
Although anxiety sensitivity is associated with a number of psychological conditions, it 
has been most studied in relation to panic disorder. Therefore, most interventions that aim 
to reduce anxiety sensitivity among nonclinical populations have been designed with the 
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prevention of panic disorder as a distal aim. As a result, the structure of these 
interventions has arisen from modifications of CBT protocols for the treatment of panic 
disorder (Barlow & Craske, 1994; Telch et al., 1993). 
Early anxiety sensitivity reduction interventions were multimodal and included: 
psychoeducation, training in cognitive reappraisal of distorted thoughts (i.e. cognitive 
restructuring), training in diaphragmatic breathing, repeated exposure to external 
situations which are associated with anxiety and panic (i.e. in-vivo exposure), and 
repeated exposure to exercises which produce bodily sensations that are associated with 
anxiety and panic (i.e. interoceptive exposure).  
Abplanalp (unpublished dissertation) conducted a large intervention study, 
comparing the efficacy of a 3-sesssion panic prevention training to non-specific control 
training among 450 university students with high anxiety sensitivity. Individuals in the 
panic prevention training group received psychoeducation, interoceptive exposure, and 
training in diaphragmatic breathing. The panic prevention training was found to decrease 
risk factors for panic disorder. Although the intervention did not influence likelihood of 
experiencing a panic attack over the 1-yr follow-up period, participants who had received 
panic prevention training reported less-panic related apprehension following a panic 
attack than those who had received control training and displayed a milder fear response 
to a carbon dioxide challenge. With regard to dispositional variables, the panic prevention 
group evidenced greater reduction in trait anxiety, fear of bodily sensations, and anxiety 
sensitivity at post-intervention and 1-yr follow-up. 
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Gardenswartz and Craske (2001) tested the efficacy of a one-day 5-hr panic 
prevention training workshop as compared to a wait-list control group on the reduction of 
anxiety sensitivity among individuals who displayed at least moderate anxiety sensitivity 
and who had experienced at least 1 panic attack in the last year. The prevention program 
included psychoeducation about panic and agoraphobia, breathing retraining, cognitive 
restructuring, interoceptive exposure training, and in-vivo exposure planning. Participants 
who had received the panic prevention workshop reported fewer panic-related symptoms 
and were less likely to have developed panic disorder at a 6-month follow-up assessment, 
however, there were no differences between groups in anxiety sensitivity reduction over 
time. 
Kenardy, McCafferty, & Rosa (2003) compared the efficacy of a self-
administered, internet-delivered 6-week panic prevention program to a wait-list control 
on reduction of anxiety sensitivity among individuals high in this trait. The intervention 
package included psychoeducation, relaxation training, cognitive restructuring, 
interoceptive exposure and relapse prevention education. Although participation in the 
program led to significantly greater reductions in symptoms of depression and anxiety-
related cognitions, there was only a marginally significant trend for the benefit of the 
prevention program on the reduction of anxiety sensitivity.  
Taken together, these panic prevention studies suggest that multimodal CBT 
packages designed after panic disorder treatment protocols result in decreased risk factors 
for panic, however, their effect on anxiety sensitivity was inconsistent.  
Brief CBT interventions 
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Additional research in anxiety sensitivity reduction suggests that the combination 
of psychoeducation and interoceptive exposure might be sufficient for reducing anxiety 
sensitivity in the nonclinical population. Schmidt, Eggleston, Woolaway-Bickel, Vasey, 
Richey, & Fitzpatrick,  (2007) tested the efficacy of a brief, one hour, anxiety sensitivity 
reduction intervention for nonclinical individuals high in this trait. The intervention 
consisted of a computer-delivered psychoeducation video and an introduction to 
interoceptive exposure; the comparison group watched a health education condition. The 
brief intervention resulted in a 30% reduction in anxiety sensitivity at post-intervention, a 
significantly greater reduction than those in the control group. In addition, those in the 
active intervention group displayed decreased fear responding to a 20% carbon dioxide 
challenge and a significantly greater reduction in anxiety sensitivity than those in the 
control group.  
At 2-yr follow-up, there was some evidence that the intervention reduced risk for 
development of psychopathology. Results showed a trend for fewer psychological 
symptoms and fewer Axis I diagnoses for those in the intervention group. Given the low 
incidence of psychopathology in this nonclinical sample, there might have been low 
statistical power to determine group differences. With regard to anxiety sensitivity, 
however, the superiority of the intervention condition in reducing anxiety sensitivity was 
not maintained; the intervention effect on anxiety sensitivity at post-intervention was 
reduced to a non-significant trend at 2-year follow-up. 
Feldner et al. (2008) augmented the strategy used by Schmidt et al. (2007) with 
the intent of reducing high anxiety sensitivity and daily smoking, two malleable risk 
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factors for panic disorder. They employed a similar research design as Schmidt et al. 
(2007) but added smoking cessation education to the intervention condition. With regard 
to anxiety sensitivity, individuals in the intervention condition showed greater reductions 
in anxiety sensitivity at post-intervention as well as 3-month follow-up; however, there 
were no group differences in anxiety sensitivity at 6-month follow-up.  
Taken together, these studies suggest that multicomponent CBT packages might 
not be necessary for reducing anxiety sensitivity in the nonclinical population. From a 
public health perspective, these prevention programs were promising as they were easily 
disseminable, easily implemented, and cost-efficient.  
 Limitations of both studies included that the interoceptive exposure was 
demonstrated and planned in one session, but there was no assessment as to whether the 
participants adhered to these exercise after leaving the laboratory. Therefore, it is not 
clear whether the participants received benefits from the interoceptive exposure 
component, the computer-administered psychoeducation component, or their 
combination. Thus, additional research is needed to dismantle the efficacy of 
psychoeducation and interoceptive exposure on the reduction of anxiety sensitivity in the 
normal population. 
Psychoeducation Alone 
Psychoeducation about the nature of stress and anxiety has been highlighted as an 
important strategy in treating anxiety disorders. Psychoeducation is often the first 
implemented strategy as it provides a foundation for the rationale of subsequent treatment 
strategies in CBT treatments for anxiety disorders. Psychoeducation about the nature of 
 23 
stress, anxiety and panic has also been included in most prevention programs targeting 
the reduction of anxiety sensitivity (e.g. Feldner et al., 2008; Kenardy et al., 2003; 
Schmidt et al., 2007).  
In an anxiety sensitivity reduction study, Maltby (unpublished dissertation) 
examined the efficacy of psychoeducation alone and psychoeducation combined with 
interoceptive exposure as compared to wait-list controls on the reduction of anxiety 
sensitivity among participants high in this trait. Results showed that all three groups 
showed significant reductions in anxiety sensitivity at post-intervention and follow-up but 
the active interventions did not lead to greater reductions in anxiety sensitivity than the 
control intervention. Maltby, Mayers, Allen and Tolin (2005) discussed that the study 
might have been limited in its power to detect intervention effects since participants were 
selected for reporting high anxiety sensitivity and regression to the mean might have 
occurred. Thus, additional research is needed in order to examine whether 
psychoeducation might be an efficacious as a singular strategy for the reduction of 
anxiety sensitivity in the at risk population. 
Interoceptive Exposure 
History of Interoceptive exposure 
Interoceptive exposure involves repeated exposure to somatic cues that resemble 
symptoms reported when individuals have anxiety or panic attacks. In Barlow‟s book 
(2001), Anxiety and its Disorders, the history of interoceptive exposure is reviewed; the 
authors stated that examples of interoceptive exposure strategies exist in early works 
within psychology but they have been misinterpreted or overlooked (White & Barlow, 
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2001). They described that Wolpe (1958) utilized repeated inhalation of CO2 as a means 
of training the reciprocal inhibition of anxiety. In addition, early studies employing 
repeated administrations of biological agents that were widely used in panic provocation 
procedures (i.e. lactate infusion and carbon dioxide) demonstrated that anxiety and fear 
were reduced with repeated administrations among individuals with anxiety and panic. 
(Van den Hout, Van der Molen, Griez & Lousberg, 1987). 
Based on this body of research and behavioral theories conceptualizing panic 
attacks as conditioned responses resulting from classical conditioning to interoceptive 
cues (Goldstein & Chambless, 1978), interoceptive exposure exercises have become a 
key component in contemporary CBT protocols for the treatment of panic disorder. 
(Barlow & Craske, 1994; Telch et al., 1993). As part of these protocols, participants are 
provided with education about interoceptive conditioning of fear response. Participants 
then complete an interoceptive assessment of various exercises that are intended to 
produce clusters of somatic sensations that are often reported during panic attacks. 
Examples of these exercises include: breathing through a coffee straw to produce 
smothering sensations, spinning to produce dizziness, and running in place to increase 
heart rate. Interoceptive exposures are then conducted for exercises that provoke a fear 
response during the initial assessment; participants are asked to repeat the exercises until 
fear is habituated or extinguished.  
Mechanisms of Interoceptive Exposure 
 Although interoceptive exposure has been highlighted as an important 
intervention strategy in the treatment of panic disorder and other anxiety disorder, the 
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mechanisms of the efficacy of interoceptive exposure remain unknown. In a review, 
Stewart and Watt (2008) discussed the application of various models of fear reduction to 
explain the mechanisms for interoceptive exposure, however, additional research is 
needed to examine the validity of these various models. 
Behavioral explanations for interoceptive exposure suggest that its efficacy can be 
explained via habituation or extinction mechanisms. The conditioning model of efficacy 
of interoceptive exposure is based on early models of fear and panic acquisition that 
proposed that fears developed from classical conditioning (Chambless & Goldstein, 
1978; Pavlov, 1928). According to these models, individuals who repeatedly experience a 
frightening event (e.g. panic attack) in the presence of somatic sensations, such as light-
headedness, might learn to fear these somatic sensations through associative learning. 
Rescorla and Solomon‟s two-process theory (1967) further describes that these 
learned fears are maintained through operant conditioning. By avoiding exposure to 
feared conditioned stimuli, individuals would reduce their anxiety but maintain their fear 
to harmless somatic sensations. 
Based on these behavioral models, repeated exposure to feared somatic sensations 
results in decreased fear response to these sensations via habituation or extinction.  
Cognitive Models of Fear Reduction 
Additional models of fear reduction after exposure describe that fear is reduced by 
providing correctional information that leads to changes in thought patterns (Rachman, 
1990). In line with these models, interoceptive exposure would provide an opportunity to 
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challenge irrational cognitions related to expectancies about anxiety-related sensations 
(e.g. If I hyperventilate, I will faint; Watt & Stewart, 2008). 
Bandura (1983) proposed that fears are experienced when individuals perceive 
that they do not have the ability to effectively cope with a given situation. In line with 
Bandura‟s model, interoceptive exposure would foster self-efficacy by providing the 
opportunity to gain behavioral mastery in situations where anxiety-related somatic 
sensations are experienced. As a result of gained self-efficacy, fear would be reduced. 
Acceptance models have also recently been proposed for explaining fear 
reduction to negative emotional states (see Hayes, 2002). Emotional acceptance involves 
the willingness to experience and accept emotions without attempts to avoid or change 
them. Applying this model, interoceptive exposure can be thought of as an opportunity to 
learn to experience and accept anxiety and related somatic sensations. 
Exercise Interventions 
Although interoceptive exposure has been highlighted as an important variable in 
the reduction of anxiety sensitivity, no studies have examined interoceptive exposure as a 
singular strategy for the reduction of anxiety sensitivity among nonclinical populations. 
Aerobic exercise has been examined as an intervention strategy for individuals with high 
anxiety sensitivity because of its multiple psychological benefits, however, it has been 
suggested that aerobic exercise might operate as an interoceptive exposure in that it 
exposes individuals to sensations of physiological arousal (Smits et al., 2008). 
Broman-Fulks, Berman, Rabian and Webster (2004) examined the effects of six 
20-minute sessions of high intensity aerobic exercise as compared to low intensity 
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exercise on individuals with high anxiety sensitivity. Anxiety sensitivity was reduced in 
both groups, but individuals in the high intensity exercise group showed reductions in 
anxiety sensitivity more quickly. In addition, there were twice as many responders (i.e.> 
1 SD change on ASI) in the high intensity group. In a second study comparing high-
intensity exercise intervention to a no-exercise control, the findings indicated that the 
intervention led to greater reductions in all subscales of the ASI-R (Broman-Fulks & 
Storey, 2008). In both studies, there was evidence that a single 20-minute session of 
exercise led to significant reductions in anxiety sensitivity scores (Broman-Fulks et al., 
2004; Broman-Fulks & Storey, 2008).  
Smits et al. (2008) expanded upon the idea of utilizing aerobic exercise as an 
anxiety sensitivity reduction strategy by placing it in the context of a CBT model. 
Participants were assigned to an exercise intervention group, an exercise + cognitive 
restructuring intervention group, or a wait-list control group. Participants in both active 
conditions were given an interoceptive exposure rationale and asked to focus on their 
bodily sensations while completing 6 20-minute sessions of intense exercise. Results 
indicated that both exercise groups displayed similar reductions in anxiety sensitivity as 
well as symptoms of anxiety and depression over time, which were superior to the wait-
list control group. In addition, mediation analyses showed that changes in anxiety and 
depression were mediated by reductions in anxiety sensitivity. Thus, there were no added 
benefits from including cognitive restructuring. In addition, there was evidence that the 
cognitive restructuring strategy was detrimental: although only a trend, attrition was 
greater in the condition that included cognitive restructuring.  
 28 
Taken together, these studies have consistently shown that exercise alone is an 
effective strategy for reducing anxiety sensitivity among nonclinical individuals. 
Although the mechanisms by which exercise leads to reductions in anxiety sensitivity are 
not known, these findings suggest that interoceptive exposure might be efficacious as a 
singular strategy. 
Interoceptive Exposure with CO2 
Although interoceptive exposure strategies are widely used, the mechanisms of 
fear reduction remain unknown. Current guidelines for interoceptive exposures suggest 
choosing exercises that elicit at least moderate fear and that produce bodily sensations 
that participants avoid or fear (Craske & Barlow, 2001; Telch et al., 1993). The reviewed 
anxiety sensitivity reduction studies conducted with individuals with high anxiety 
sensitivity employed traditional interoceptive exposure exercises used in panic disorder 
treatment protocols (e.g. running in place or voluntary hyperventilation, e.g. Schimdt et 
al., 2007; Gardenswartz & Craske, 2001) or aerobic exercise as methods of interoceptive 
exposure (e.g. Smits et al., 2008). Because individuals with high anxiety sensitivity in the 
normal population might not display as elevated anxiety sensitivity as individuals with 
panic disorder, they might not demonstrate as much sensitivity to a variety of 
interoceptive cues. As initial fear activation is central to the utility of interoceptive 
exposure exercises, the intensity of somatic sensations produced by traditional 
interoceptive exposure exercises and aerobic exercise may not be sufficient to activate 
fear in nonclinical individuals with high anxiety sensitivity. Therefore, the interoceptive 
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exposure exercises that were designed for panic disorder treatment might not be as 
relevant to this at risk population. 
In panic provocation studies, inhalation of carbon dioxide/oxygen gas mixtures 
has been shown to consistently elicit fear and panic in individuals with high anxiety 
sensitivity (Harrington, Schmidt & Telch; 1996; Zvolensky et al., 1997, 1999). The 
inhalation of carbon dioxide produces multiple physiological sensations that are often 
reported during anxiety and panic attacks including chest tightness, feelings of 
breathlessness, light-headedness, and derealization; therefore, using carbon dioxide as an 
interoceptive exposure exercise may have a greater likelihood of activating fear and of 
resembling physiological sensations that are experienced during high anxiety sensitivity. 
Thus, administering repeated inhalations of carbon dioxide gas mixture may serve as a 
more effective interoceptive exposure strategy for individuals with high anxiety 
sensitivity. 
Interoceptive exposure with CO2  for Panic Patients 
A small number of studies have tested the efficacy of repeated inhalations of CO2 
as a singular intervention strategy for the treatment of panic disorder (Griez and Van den 
Hout, 1986; Van den Hout, Van der Molen, Griez, & Lousberg, 1987). In a cross-over 
study, Griez et al. (1986) compared the efficacy of interoceptive exposure using CO2 to 
propanolol (Beta-blocker) among 14 patients with panic disorder. Both interventions 
were administered over a 2-week period, with the CO2 intervention consisting of 6 90-
minute sessions. The CO2 intervention resulted in a significant reduction in number of 
panic attacks (50%), while the 38% reduction after the treatment with propanolol did not 
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reach statistical significance. The CO2 intervention also resulted in greater reductions in 
fear of interoceptive sensations. In addition, most patients maintained the benefits from 
the CO2/propanolol intervention at the 6-month follow-up.  
In a case study, Beck, Shipherd, and Zebb (1997) examined the influence of 
interoceptive exposure with 35% C02 on 17 patients with panic disorder. All participants 
completed 6 sessions consisting of 12 inhalation trials. They found that individuals 
displayed one of two fear response patterns within-sessions: habituation (participant‟s 
slope ≤ .50) or nonhabituation (participant‟s slope ≤ .50); these patterns were also found 
in a previous study (Beck & Shipherd, 1997). Although both patterns of response resulted 
in reduced panic, panic-related fears, and general anxiety, the change in symptoms 
appeared to occur faster among habituators. With regard to anxiety sensitivity, two 
patterns emerged as well. Nonhabituators showed an increase in anxiety sensitivity at 
post-intervention, and then a decrease at follow-up; habituators showed significant 
reductions in anxiety sensitivity, and these were maintained at one-month follow-up. 
Therefore, results of this study suggest that interoceptive exposure with repeated 
inhalations of CO2 is a beneficial treatment for panic disorder but the effect of this 
singular strategy on reduction of anxiety sensitivity depends on fear response patterns to 
the interoceptive exposure exercise. 
Repeated Inhalations of CO2 with Nonclinical Participants 
 Repeated inhalations of CO2 has not been tested in prevention studies aiming to 
reduce anxiety sensitivity among nonclinical individuals, however, two studies have 
administered repeated inhalations of carbon dioxide as a method of examining patterns of 
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fear responding among nonclinical populations. Beck, Shipherd, and Read (1999) 
exposed individuals with high anxiety to 12 trials of 35% CO2/65% O2 gas inhalations. 
Participants varied in their individual patterns of fear responding over time, with 37% of 
individuals demonstrating habituation, 47% demonstrating sensitization, and 16% 
remaining stable. In a replication utilizing a 20% CO2/80% O2 gas inhalations, a greater 
proportion of individuals displayed habituation, with 67% of participants classified as 
habituators and 33% classified as nonhabituators (Beck & Wolf, 2001).  
 The primary aim of the previous studies was to examine fear responding to 
repeated presentation of CO2. The studies suggest different individual patterns of fear 
responding over time, with 37%-67% of individuals demonstrating within-session 
habituation. Yet, no studies have examined the effects of repeated inhalations of CO2 on 
the reduction of anxiety sensitivity in the at risk population.  
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Chapter 3: Present Study 
The primary aim of the present randomized secondary prevention trial was to 
enhance knowledge on methods for reducing anxiety sensitivity among persons who 
display elevations on this dispositional variable that has been consistently shown to be 
associated with anxiety disorders as well as other mental health problems. This secondary 
prevention trial tested the singular and combined efficacy of two commonly used 
strategies in multi-component interventions for reducing anxiety sensitivity: (a) anxiety 
psychoeducation emphasizing the benign nature of stress and (b) interoceptive exposure 
(i.e. repeated inhalations of 35% CO2 gas mixture). 
All participants received two components of intervention: education and repeated 
inhalations of a gas mixture. To provide a stringent control for non-specific effects 
associated with anxiety psychoeducation (A_Ed) and interoceptive exposure with CO2 
(CO2), two control strategies were included in the study design: general health and 
nutrition education (H_Ed) and repeated inhalations of regular room air (AIR). 
Participants were not aware of the contents of the gas mixture they received.  
Participants were matched on baseline anxiety sensitivity and community status. 
Utilizing a 2x2 design, participants were randomly assigned to one of four conditions: 
anxiety psychoeducation + carbon dioxide exposure (A_Ed + CO2), health education + 
carbon dioxide exposure (H_Ed + CO2), anxiety psychoeducation + breathing air (A_Ed 
+ AIR), and health education + breathing air (H_Ed+AIR). Therefore, the present study 
allowed for the dismantling of two commonly combined intervention strategies: 
interoceptive exposure and psychoeducation.  
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The proposed hypotheses are below: 
1. Each of the active conditions (A_Ed + CO2, H_Ed+CO2, A_Ed+AIR) will lead to 
greater reductions in anxiety sensitivity as compared to the double placebo group 
(H_Ed+AIR) , with the combination of psychoeducation and interoceptive 
exposure strategies (A_Ed + CO2) yielding the greatest reduction in anxiety 
sensitivity. Although the combination group will consistently yield the greatest 
reductions in anxiety sensitivity, the difference between the conditions including 
only one active strategy (A_Ed+AIR, H_Ed + CO2) will depend on the specific 
domain of anxiety sensitivity. This prediction is based on the conceptual match 
between the intervention strategy and the outcome. 
a. Participants in the A_Ed+AIR and H_Ed + CO2 conditions will display 
similar reductions on the ASI-3 full scale. 
b. For ASI -physical concerns subscale and fear of bodily sensations, the 
H_Ed + CO2 condition will yield greater reductions than the A_Ed + AIR 
condition.  
c. For ASI-cognitive concerns subscale, the A_Ed + AIR will outperform the 
H_Ed + CO2.  
d. Participants in the H_Ed + CO2 will exhibit less fear in response to 
behavioral challenges as compared to individuals in the A_Ed + AIR 
condition. 
2. Reductions in anxiety sensitivity will be maintained over the one-month follow-
up period for all active conditions (A_Ed + CO2, H_Ed+CO2, A_Ed+AIR). 
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3. Higher baseline anxiety sensitivity, community status, and diagnostic status will 
moderate reductions in anxiety sensitivity. 
4. Changes in emotional acceptance and distress tolerance will mediate the effect of 
experimental condition on reduction of anxiety sensitivity. 
5. Both conditions that include interoceptive exposure with carbon dioxide (H_Ed + 
CO2, A_Ed + CO2) will demonstrate within-session and between-session 
habituation of fear response to inhalation of CO2; the group that receives both 





Participants (n=102) were recruited from the general Austin community via flyers 
and from the University of Texas Department of Psychology undergraduate research 
pool. Students enrolled in introductory psychology or introduction to clinical psychology 
received experimental credit for their participation. Participants ranged in age from 18 to 
49 (M=19.58, SD=3.59), 77% were female, and 41% met for a current anxiety or mood 
disorder. The ethnic makeup was diverse: 51% Caucasian, 30% Hispanic, 18% Asian 
American, 1% African American, and 0% other. There were no differences between 
conditions based on gender, age, ethnicity, or diagnostic status. 
The screening for the study eligibility consisted of two parts. Participants 
completed the anxiety sensitivity index (ASI-3), the medical history questionnaire 
(MHQ), and a demographics questionnaire in a pre-screening survey via the Internet. 
Individuals 18 and older who met inclusion criteria based on the ASI-3 (i.e., ASI > 1 SD 
above the mean) and who did not report medical contraindications for the inhalation of a 
carbon dioxide gas mixture were invited to the laboratory to participate in the present 
study. 
At the face-to-face screening assessment, two additional eligibility requirements 
were imposed. In order to meet eligibility criteria, participants were required to report 
marked anxiety sensitivity (i.e. ASI-3> 1 SD above nonclinical mean) according to the 
ASI-3 at this second pre-intervention time point. In addition, participants were required to 
demonstrate at least mild somatic sensitivity, as indicated by a fear response of greater or 
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equal to 30 on a scale of 0-100 to a 2-min voluntary hyperventilation challenge. These 
additional inclusion criteria were imposed to ensure that study participants exhibited 
heightened anxiety sensitivity that was stable across time as well as across assessment 
modalities.  
Exclusion criteria included: (a) history of medical conditions that could be 
aggravated by inhalation of CO2 including: cardiovascular disorders (e.g., cardiac 
arrhythmia, cardiac failure), respiratory disorders (e.g., asthma, lung fibrosis), high blood 
pressure, epilepsy, stroke or seizures; (b) change in dosage of psychotropic medication 
during the past two weeks, (d) pregnant or lactating. 
Figure 1. Participant Flow 
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EXPERIMENTAL DESIGN 
The experimental design was a 2x2 randomized intervention study with four 
experimental conditions. Participants were matched on pre-intervention anxiety 
sensitivity and community status. Using stratified randomization, participants were 
randomly assigned to receive a combination of psychoeducation and exposure in one of 
four intervention conditions: (a) anxiety psychoeducation + CO2 interoceptive exposure 
(A_Ed+CO2); (b) anxiety psychoeducation + breathing air exposure (A_Ed + AIR); (c) 
health psychoeducation + CO2 interoceptive exposure (H_Ed + CO2); (d) health 
psychoeducation + breathing air exposure (H_Ed+AIR). The interventions were matched 
on duration of psychoeducation and exposure. 
APPARATUS 
There were two 212 cubic foot cylinder tanks provided by Praxair Distribution, 
Inc. One tank contained 35% carbon dioxide/65% oxygen medical grade compressed air 
(MM OXCD35-K) and the other tank contained medical grade compressed breathing air 
(AI M-K). Both tanks were covered with white butcher paper so they appeared identical. 
The gas masks (SAL 8130) were connected to the tanks through gas control regulators 
(WES M1-346-PG).  
MEASURES  
Demographic Questionnaire 
 The demographic questionnaire is an author constructed questionnaire which 
asks individuals about age, gender, and ethnicity. 
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Medical History Questionnaire 
The Medical History Questionnaire (MHQ) is an author constructed 10-item 
medical history questionnaire designed to identify participants with medical 
contraindications to inhalation of CO2. 
Anxiety Sensitivity Measures 
Anxiety Sensitivity Index-3 
The Anxiety Sensitivity Index-3 (ASI-3; Taylor et al., 2007) is an 18-item scale 
measuring anxiety sensitivity. Items such as „It scares me when my heart beats rapidly‟ 
and „When I cannot keep my mind on a task, I worry that I might be going crazy‟ are 
rated on a 5-point („very little‟ to „very much‟) scale. Using many items from previous 
versions of the Anxiety Sensitivity Index, the scale was designed to assess three factors: 
physical concerns, cognitive concerns, and social concerns. Confirmatory factor analyses 
of six replication samples, including clinical and nonclinical samples from different 
countries, supported the 3-factor solution. The ASI-3 displayed good reliability and 
validity, and there was evidence of improved psychometric properties over the original 
ASI (Taylor et al., 2007). 
Body Sensations Questionnaire   
The Body Sensations Questionnaire (Chambless et al., 1984) is a 17-item measure 
of fears associated with physical symptoms of arousal commonly experienced during 
anxiety (e.g. heart palpitations, dizziness, numbness in arms or legs). Each item is rated 
on a 5-point Likert scale from 1 (not at all) to 5 (extremely). The scale demonstrated high 
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internal consistency (cronbach‟s alpha = .87; Schmidt & Telch, 1994) and adequate test-
retest reliability (Chambless et al., 1984). 
Behavioral challenges 
 For behavioral measures of anxiety sensitivity, participants engaged in behavioral 
challenges intended to induce somatic reactions that resemble those that are commonly 
reported during anxiety/panic episodes. These tasks include: a single vital capacity 
inhalation of 35% carbon dioxide/65% oxygen gas, voluntary hyperventilation (up to 2 
min), breathing through a coffee straw (up to 2 min), and spinning in a chair (up to 15 
sec). The carbon dioxide challenge has been extensively used in panic provocation 
studies. The voluntary hyperventilation, straw-breathing, and spinning challenges have 
been widely used in panic treatment protocols. 
With each behavioral challenge, participants‟ anticipatory anxiety before each 
exposure trial and fear response following each trial was measured using a Subjective 
Units of Distress Scale (0-100 Likert Scale). This is a common method of assessing 
subjective fear and anxiety in anxiety studies. In addition, participants‟ experience of 
physical and cognitive symptoms of anxiety will be recorded. These additional questions 
are modifications of items from the Acute Panic Inventory (API; Leibowitz, Gorman, 
Fyer, Dillon, & Klein, 1984). 
Other Measures of Psychopathology 
State-Trait Anxiety Inventory- Trait subscale 
The State Trait Anxiety Inventory-Trait (STAI-T) subscale measures trait anxiety 
(Spielberger, Gorsuch, & Lushene, 1970). It is composed of 20 items that are scored on a 
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four-point Likert scale ranging from Not At All (1) to Very Much So (4). Examples of 
items include „I feel nervous and restless,‟ and „I have disturbing thoughts.‟  The scale 
has demonstrated good internal consistency (α=.92) and test-retest reliability (r=.86; 
Spielberger et al., 1983). Because previous anxiety sensitivity reduction studies 
demonstrated improvements in trait anxiety (Smits et al., 2008; Abplanalp, unpublished 
dissertation), it is included as an additional outcome measure. 
Beck Depression Inventory-II  
The Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) is a 21-
item self-report measure designed to assess symptoms of major depression (e.g. sadness, 
loss of pleasure, loss of energy). The BDI-II possesses good internal consistency (α=.92; 
Beck et al., 1996) and distinguishes well between those with and without a diagnosis of 
major depression (Arnau, Meagher, Norris, & Bramson, 2001). The BDI-II is the second 
version of the measure, with changes designed to match criteria of major depressive 
disorders (MDD) in the DSM-IV.  
Brief-Fear of Negative Evaluation Scale 
The Brief-Fear of Negative Evaluation Scale  (BFNE; Leary, 1983) is a 12-item 
scale that uses a 5-point Likert scale to measure fear of negative evaluation ranging from 
0 (not at all characteristic of me) to 4 (extremely characteristic of me). Examples of items 
include: “I am afraid that others will not approve of me,” and “I am afraid that people 
will find fault with me.” Confirmatory factor analysis supported a two-factor solution 
corresponding to positive and reverse scored items. Internal consistency was good for the 
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full scale (a = .80) and acceptable for the positive scored factor (a= .94) and reverse 
scored factor (a= .73) (Duke, Krishnan, Faith & Storch, 2006).  
Measures of fear response to exposure 
Interoceptive Exposure Process Measure 
Participants‟ anticipatory anxiety before each exposure trial and subjective fear 
response following each trial will be measures using a Subjective Units of Distress Scale 
(0-100 Likert Scale). This is a common method of assessing subjective fear and anxiety 
in anxiety studies. In addition, physical reactions to the exposure trials will be assessed 
using items modified from the Acute Panic Inventory (API). 
Acute Panic Inventory 
The Acute Panic Inventory (API; Liebowitz, Gorman, Fyer, Dillon, & Klein, 
1984) is a widely used self-report instrument for assessing physical and affective 
reactions to biological challenges. Using a 0 (none) to 3 (extreme) Likert-scale, 
participants rate 29 potential panic-related symptoms on severity. A Likert-scale ranging 
from 0 (not disturbed at all) to 100 (the worst imaginable experience) measures peak fear. 
The API also includes a "Yes" or "No" response question to assess the occurrence of 
subjective panic in response to the challenge. 
Diagnostic Status 
The Composite International Diagnostic Interview  
The CIDI (CIDI; World Health Organization, 1997) is a brief structured interview 
that assesses symptoms and presence of mental health disorders derived from DSM-IV 
diagnostic criteria. The CIDI is a widely used for interview for diagnosis of psychiatric 
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disorders, and has demonstrated good sensitivity and specificity (Peters & Andrews, 
1995), excellent inter-rater reliability, adequate test-retest reliability, and good validity 
(Andrews & Peters, 1998).  
Putative Mediators 
Acceptance and Action Questionnaire  
The Acceptance and Action Questionnaire (AAQ; Hayes et al., 2004) measures 
experiential avoidance and emotional acceptance. The scale is a 9-item instrument in 
which statements are rated on a 1 (never true) to 9 (always true) Likert scale, with higher 
scores reflecting greater experiential avoidance. The AAQ-R showed adequate internal 
consistency (α = .70) and test-retest reliability for the 16-item version was .64. (Hayes et 
al., 2004). 
Distress Tolerance Inventory  
The Distress Tolerance Inventory (DTI; Telch & Cougle, in prep) is a 10-item 
scale assessing tolerance for physical or emotional distress. Statements are rated on a 1 
(strongly agree) to 6 (strongly disagree) scale. Statements include „I can usually handle 
feelings of emotional upset quite well‟ and „I‟ll take fairly extreme measures to stop 
physical discomfort or pain.‟ Factor analysis revealed that the ten items fit neatly into two 
five-item physical and emotional distress tolerance subscales. The internal consistency 
was .86 for the total scale, and .87 and .85 for the emotional distress tolerance and 
physical distress tolerance subscales, respectively. The scale also displayed good test-
retest reliability (overall: r=.85, p<.0001; physical: r=.84, and emotional: r=.85). An 
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initial validation study found the DTI to significantly predict tolerance of and distraction 
from film-clips inducing sadness, anger, disgust, and fear (Telch & Cougle, in prep).  
Manipulation and Credibility Check 
Credibility/Expectancy Questionnaire  
 Credibility and expectancy of the interventions will be assessed using a modified 
version of the Credibility/Expectancy Questionnaire (CEQ), which is a 6-item scale in 
which items are rated on a 0 (not at all) to 10 (extremely) Likert-type scale. Examples of 
questions include: „„At this point, how logical does the intervention offered to you 
seem?‟‟ and „„How much improvement in your anxiety sensitivity do think will occur?‟‟. 
The CEQ has demonstrated high internal consistency and test-retest reliability (Devilly & 
Borkovec, 2000).   
Manipulation Check of Full Capacity Breath 
 Using a 0-100 Likert Scale, the research assistant reported their confidence that 
the participant inhaled a full vital capacity breath of the gas mixture after each trial. 
Perception of Assignment 
 At the end of the one-month follow-up assessment, participants were told that 
there were two types of gas mixtures (placebo and active). They were asked to indicate 




Participants completed the anxiety sensitivity index (ASI-3), the medical history 
questionnaire (MHQ), and a demographics questionnaire via the Internet before entering 
the study. Individuals 18 and older who met inclusion criteria based on the ASI-3 (i.e., 
ASI > 1 SD above the nonclinical mean) and who did not report medical 
contraindications were invited to the laboratory to participate in the present study. 
Screening Assessment 
After giving informed consent, participants completed the baseline questionnaires 
which included measures of anxiety sensitivity (ASI-3, BSQ), fear of negative evaluation 
(BFNE), other psychological dispositions (STAI-T, BDI-II) and putative mediators 
(AAQ-9, DTI).Participants who did not report elevated anxiety sensitivity on the ASI-3 at 
this second time point (i.e. ASI-3 < 1 SD above the mean) were informed that they were 
not eligible for the intervention phase of the study. 
Participants who reported elevated anxiety sensitivity based on the ASI-3 were 
administered the second face-to-face screening assessment: a 2-min voluntary 
hyperventilation challenge. Participants who reported a fear response less than 30 out of 
100 to the hyperventilation challenge were informed that they were not eligible for the 
intervention phase of the study. 
Individuals who displayed marked anxiety sensitivity at the screening assessment 
according to the ASI-3 and who reported at least mild fear to the voluntary 
hyperventilation challenge (peak fear ≥ 30) were deemed eligible for the study. 
 45 
Participants were matched on pre-intervention anxiety sensitivity and community 
status. Using stratified randomization, participants were randomly assigned to receive a 
combination of psychoeducation and exposure in one of four intervention conditions: (a) 
anxiety psychoeducation + CO2 interoceptive exposure (A_Ed+CO2); (b) anxiety 
psychoeducation + breathing air exposure (A_Ed + AIR); (c) health psychoeducation + 
CO2 interoceptive exposure (H_Ed + CO2); (d) health psychoeducation + breathing air 
exposure (H_Ed + AIR). 
Intervention Session 1 
Psychoeducation 
 The first intervention session immediately followed the screening assessment. 
The intervention began with the psychoeducation component, which consisted of 
participants watching an animated powerpoint presentation on a computer screen (anxiety 
psychoeducation or health psychoeducation). These materials have been used in a 
previous studies (Feldner et al., 2008; Schmidt et al., 2007) and are of equal length.  
 The anxiety psychoeducation presentation describes the nature of stress and 
the effects of stress on the body. The presentation emphasizes the benign nature of stress, 
providing corrective information regarding the relationship between stress and 
physiological arousal. Finally, information about the interoceptive conditioning of fear is 
given. The control presentation focuses on health and nutrition, and the presentation does 
not address fear or stress. Individuals in the A_Ed + AIR and A_Ed+CO2 conditions 
watched the anxiety psychoeducation presentation while individuals in the H_Ed +CO2 
and H_Ed+AIR conditions watched the health education video. 
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Inhalation Training 
The second step of the first intervention session involved training the participants 
in the gas inhalation procedure. The training procedure was identical for all participants. 
The research assistants describe the rationale for interoceptive exposure, emphasizing 
that people habituate to uncomfortable sensations with repeated exposure. The 
participants viewed a 2-min video clip on the computer describing the inhalation 
procedure. The video explained that they would be inhaling a gas mixture that is not 
harmful but may elicit some uncomfortable sensations. The procedures for inhaling the 
gas mixture were then outlined. First, participants were instructed to exhale all of the air 
from their lungs and place the gas mask over their mouth and nose to ensure that only the 
gas mixture was being inhaled. Second, the video emphasized that the participants should 
take a full, deep breath of the gas mixture before removing the mask from their face. 
Third, the participants were instructed to hold the gas mixture in their lungs for five 
additional seconds before exhaling. Finally, participants were shown a demonstration of 
an individual undergoing a carbon dioxide challenge. 
Participants were then led to a chair next to the two gas tanks to practice the 
inhalation procedure without receiving any gas mixture. The research assistant handed 
the gas mask to the participant. The participant practiced the inhalation procedure, and 
the research assistant provided corrective feedback to ensure a full vital capacity 
inhalation. Participants then completed the modified CEQ, reporting the credibility of the 
intervention and their expectancy of intervention efficacy. 
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Repeated inhalations of gas mixture 
 The inhalation component consisted of 6 trials of a single vital capacity 
inhalation of the training gas mixture (35% CO2/65% O2 or breathing air). Before each 
trial, the research assistant asked participants about their anticipatory anxiety with regard 
to the next trial. There was a 2 min inter-trial recovery period between each trial during 
which participants completed the intervention process measure. In addition, the research 
assistants completed their reports on their confidence that the participant inhaled a full 
vital capacity breath after each trial. At the end of the 6 trials of interoceptive exposure, 
participants completed the Acute Panic Inventory (API). Participants in the A_Ed + AIR 
and H_Ed +AIR completed the exposure with breathing air and individuals in the 
H_Ed+CO2 and A_Ed+CO2 completed the interoceptive exposure with the carbon 
dioxide gas mixture. 
Intervention Sessions 2 and 3  
 The procedure for the intervention sessions 2 and 3 were identical and consisted 
of two parts: completion of psychological measures and exposure with repeated gas 
inhalations. Participants first completed the anxiety sensitivity index (ASI-3) and putative 
mediator measures (DTI and AAQ). Participants then completed the exposure to six trials 
of gas inhalations that were conducted in intervention session 1.  
Post-intervention Assessment 
 The post-intervention assessment consisted of three parts: a semi-structured 
diagnostic interview (CIDI-auto), completion of the post-intervention battery, and 
participation in the behavioral challenges. 
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The research assistant administered the CIDI-auto to determine presence of 
anxiety and mood disorders and participants completed the post-intervention assessment 
battery (same outcome assessments given at pre-intervention). Participants then engaged 
in the behavioral challenges. Regardless of the gas mixture received during the 
intervention sessions, participants in all conditions underwent a carbon dioxide challenge. 
To balance expectations, participants were told that they may or may not receive the gas 
mixture that they received during the exposure sessions. Participants then completed the 
hyperventilation challenge, spinning challenge, and straw breathing challenge. Following 
each of the behavioral challenges, participants completed process measures. 
One-Month Follow-up Assessment 
One month after post-intervention assessment, participants completed the self-
report measures and behavioral challenges that were administered as at post-intervention, 
however, the CIDI-auto was not readministered. In addition, participants were asked 
about their perception of whether they were assigned to an active or placebo gas mixture. 
Debriefing included a written debriefing statement, which indicated the nature and 
purpose of the experiment and included the contact information for the laboratory for the 







There were no pre-intervention differences between conditions on demographic or 













































































F (3,98) 0.12 0.92 0.53 0.90 1.43 1.36 2.38 1.49 0.17 1.33 
 




 Eight participants dropped out during the intervention. Overall, there was 7.7% 
dropout (13.04% in A_Ed+CO2, 11.54% in H_Ed+CO2, 4.00% in A_Ed+AIR, and 3.7% 
in H_Ed+AIR).  Two-tailed Fisher‟s exact test indicated there was not a significant 
difference between proportion of dropout based on condition (p=.52). 
INTEGRITY OF MANIPULATION 
 Independent samples t-tests were conducted to examine differences in intensity of 
sensations, symptoms of breathlessness, and symptoms of lightheadedness in response to 
the type of gas mixture. For all outcome variables, there was a significant difference 




 CO2 conditions AIR conditions  
Intensity of physical sensations 
 M SD M SD t 
Session 1 6.23 2.24 4.14 2.93 -3.84*** 
Session 2 3.48 2.47 2.36 2.49 -2.18* 
Session 3 3.02 2.48 1.58 1.96 -3.14** 
Lightheadedness sensations 
 M SD M SD t 
Session 1 1.89 1.04 1.30 0.95 -2.85** 
Session 2 1.50 1.07 0.84 0.91 -3.23** 
Session 3 1.84 1.01 0.94 0.89 -4.60*** 
 
Breathlessness sensations 
 M SD M SD t 
Session 1 2.14 0.90 1.38 0.97 -3.90*** 
Session 2 1.82 1.62 1.00 0.99 -3.00** 








Primary outcome analyses examined the effects of type of education (EDU) and 
type of gas mixture (GAS) on anxiety sensitivity at post-intervention and follow-up, 
indexed as a decrease in self-reported anxiety sensitivity and its lower order factors as 
well as fear response to behavioral challenges. Analyses of each outcome variable 
examined: (1) within-condition reductions in outcome variables, (2) the effects of type of 
education and type of gas mixture on outcome variables at post-intervention and follow-
up. In addition, moderator analyses were conducted to examine whether baseline anxiety 
sensitivity and diagnostic status moderated the effects of GAS and EDU on outcome 
variables. To examine specificity of anxiety psychoeducation and interoceptive exposure 
with CO2 strategies, similar analyses were conducted with psychological disposition 
variables that are related to anxiety sensitivity (i.e. trait anxiety, depression symptoms, 
fear of negative evaluation, fear of bodily sensations). 
Within-condition analyses examined changes in each outcome variable from pre-
intervention to post-intervention as well as pre-intervention to follow-up using paired t-
tests. 
Separate hierarchical linear regression analyses were conducted for all outcome 
measures at post-intervention assessment as well as at one-month follow-up assessment. 
For each outcome variable, the main effects of EDU and GAS as well as their interaction 
were examined after including baseline scores of the dependent variable as a covariate.  
Similar hierarchical linear regression analyses were conducted to examine the 
effects of putative moderators (i.e. baseline anxiety sensitivity and diagnostic status) on 
the effects of intervention strategies on all outcome variables at post-intervention and 
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one-month follow-up. For each model, the 3-way interaction (EDU X GAS X moderator) 
was examined after controlling for baseline score of the outcome variable. The model 
was condensed by removing terms that were not significant in a backward stepwise 
fashion until only terms that were at least marginally significant (p <.10) remained.  
Within-condition analyses showed significant reductions from pre-intervention to 
post-intervention and pre-intervention to follow-up intervention in anxiety sensitivity for 
all conditions. In addition, there were significant reductions in other outcome variables.  
There were no significant effects of EDU, GAS, or their interaction for any of the 
outcome variables at post-intervention or follow-up. In addition, the putative moderator 
variables did not influence effects of intervention strategies on any outcome variables at 
post-intervention or follow-up. Therefore, there were no differential effects based on 
intervention strategies for any of the primary outcome analyses. 
 






Session 1 37.48 (8.60) 35.88 (8.22) 35.58 (7.71) 36.08 (8.02) 
Session 2 31.75 (7.77) 32.50 (10.67) 31.50 (9.60) 30.65 (9.25) 
Session 3 29.35 (10.30) 29.92 (12.46) 26.42 (10.62) 27.46 (10.76) 
Post 27.80 (8.70) 29.29 (12.97) 27.04 (11.16) 25.65 (11.92) 
Follow-up 29.00 (10.17) 29.09 (12.86) 25.66 (13.11) 28.27 (11.63) 
 













Session 1 10.95 (4.42) 8.96 (5.10) 10.42 (4.62) 9.96 (4.61) 
Session 2 9.35 (5.35) 8.50 (5.23) 9.13 (4.88) 8.27 (4.94) 
Session 3 8.60 (6.27) 7.08 (5.14) 6.67 (5.00) 6.53 (4.63) 
Post 8.00 (5.78) 6.79 (5.57) 7.08 (5.19) 5.73 (4.46) 
Follow-up 7.85 (5.83) 7.59 (5.94) 7.13 (5.30) 7.50 (5.20) 
Social Concerns 
 
Session 1 16.74 (3.52) 17.20 (3.82) 16.20 (4.12) 16.19 (3.91) 
Session 2 14.30 (4.70) 16.00 (4.79) 15.58 (5.14) 15.04 (5.22) 
Session 3 13.75 (5.04) 15.86 (5.40) 13.75 (6.19) 14.58 (5.10) 
Post 13.75 (5.47) 16.04 (5.87) 14.33 (6.37) 13.92 (5.48) 
Follow-up 13.85 (4.40) 15.09 (5.78) 13.17 (6.70) 14.46 (5.61) 
Cognitive Concerns 
 
Session 1 9.79 (5.30) 9.71 (4.84) 8.95 (5.09) 9.92 (4.21) 
Session 2 8.10 (5.43) 8.00 (4.83) 6.79 (4.88) 7.35 (5.02) 
Session 3 7.00 (4.81) 6.96 (5.56) 6.00 (5.76) 6.35 (5.64) 
Post 6.05 (4.59) 6.46 (5.35) 5.63 (5.30) 6.00 (5.46) 
Follow-up 7.30 (4.74) 6.41 (5.35) 5.38 (5.45) 6.31 (4.61) 
 













Pre 50.50 (19.59) 59.58 (19.44) 55.42 (16.68) 58.08 (19.80) 
Post 35.00 (23.73) 40.42 (24.40) 34.58 (27.34) 38.85 (29.84) 
Follow-up 30.50 (27.04) 33.18 (26.07) 22.92 (24.93) 32.80 (30.62) 
                                                                  CO2 Challenge 
 
Post 32.50 (27.89) 25.83 (21.24) 42.92 (31.13) 36.15 (32.63) 
Follow-up 28.00 (22.85) 28.64 (21.22) 27.92 (27.34) 34.80 (30.70) 
Spinning Challenge 
 
Post  21.50 (23.68) 12.08 (16.41) 17.50 (24.18) 24.23 (28.59) 
Follow-up  19.50 (17.91) 25.00 (31.12) 11.67 (22.20) 19.60 (23.71) 
Straw-breathing Challenge 
 
Post 30.50 (26.65) 22.08 (22.06) 33.33 (28.84) 28.08 (26.08) 
Follow-up 23.00 (24.52) 25.00 (21.77) 30.00 (30.36) 24.40 (31.37) 
 













Pre 48.26 (7.68) 53.54 (6.69) 50.92 (8.79) 50.35 (8.90) 
Post 45.15 (8.17) 51.58 (8.45) 49.08 (10.05) 48.31 (11.11) 
Follow-up 46.05 (5.91) 51.82 (7.18) 49.71 (8.12) 49.38 (8.61) 
Depression Symptoms 
 
Pre 17.84 (6.83) 20.33 (7.95) 19.12 (8.07) 18.58 (9.75) 
Post 12.55 (8.36) 15.46 (9.14) 14.79 (8.46) 15.65 (10.61) 
Follow-up 10.65 (6.20) 14.45 (10.00) 13.71 (8.33) 14.56 (11.71) 
Fear of Negative Evaluation 
 
Pre 43.68 (7.59) 45.92 (6.98) 45.54 (7.27) 43.81 (7.34) 
Post 42.20 (7.45) 44.38 (7.13) 42.75 (6.62) 41.62 (7.85) 
Follow-up 41.75 (7.48) 44.68 (7.13) 42.92 (7.12) 42.61 (8.30) 
Body Sensations Questionnaire 
 
Pre 3.06 (0.69) 2.80 (0.66) 3.13 (0.54) 3.00 (0.66) 
Post 2.85 (0.64) 2.42 (0.66) 2.55 (0.83) 2.50 (0.87) 
Follow-up 2.53 (0.64) 2.34 (0.66) 2.45 (0.85) 2.54 (0.69) 
 
Table 6. Means and standard deviations for other psychological dispositions 
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 Pre-Post Pre-FU Pre-Post Pre-FU Pre-Post Pre-FU Pre-Post Pre-FU 
Anxiety sensitivity 
Anxiety sensitivity 
6.74*** 5.62*** 3.66** 3.77** 3.78** 4.33*** 5.78*** 3.77** 
AS physical 
3.66** 3.92** 2.89** 1.69 3.55** 3.17** 5.14*** 2.68* 
AS cognitive 
4.13** 3.35** 4.32*** 4.28*** 3.85** 4.13*** 5.19*** 5.14*** 
AS social 
3.00** 3.57** 1.55 2.56* 2.12* 3.91** 2.70* 1.78
 a
 
Other psychological dispositions 
Trait anxiety 






2.90*** 4.77*** 4.61*** 4.84*** 3.53** 4.36*** 2.69* 3.07** 
Fear of bodily  
sensations 
5.21*** 4.97*** 3.08** 4.26*** 4.62*** 4.93*** 3.37** 3.83** 
Fear of negative 
evaluation 
 .49 .65 1.95
a
 2.48* 3.79** 2.97** 2.22* 1.06 
 
a
p<.10,*p<.05, **p<.01, ***p<.0001 
 
Table 7. Within-condition paired t-tests 
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 Pre-Post Pre-FU Pre-Post Pre-FU Pre-Post Pre-FU Pre-Post Pre-FU 
Anxiety sensitivity 
Anxiety sensitivity 
1.43 1.17 0.87 0.89 0.80 0.98 1.23 0.77 
AS physical 
0.75 0.74 0.60 0.36 0.73 0.65 1.01 0.53 
AS social 
0.82 0.89 0.37 0.56 0.49 0.86 0.56 0.37 
AS cognitive 
0.86 0.69 0.89 0.92 0.78 0.84 1.07 1.01 
Other psychological dispositions 
Trait anxiety 
0.44 0.23 0.61 0.40 0.38 0.21 0.39 0.14 
Depression 
0.72 1.15 0.96 0.96 0.72 0.89 0.53 0.57 
Fear of negative 
evaluation 
0.24 0.24 0.40 0.29 0.83 0.61 0.44 0.22 
Fear of bodily  
sensations 0.49 1.09 0.63 0.79 1.04 1.12 0.68 0.74 
 
Table 8. Within-condition Cohen’s d effect sizes for self-report outcome measures 
 
Clinically Significant Change 
 In accordance with the guidelines put forth by Jacobsen and Truax (1992), 
participants were classified as exhibiting clinically significant change if they 
demonstrated reliable change in reduction in anxiety sensitivity and if their anxiety 
sensitivity scores at the end point were less than the midpoint between the sample mean 
(the “at risk” group mean) and the normative mean. Reliable change is defined as 1.96 X 
SD at baseline X SQRT(2) X SQRT (1-reliability). The midpoint between the “at risk” 
sample and the normative sample was determined by calculating SD (normative data) X 
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M (“at risk” sample) + SD (“at risk” sample) + M (normative data)/ SD (normative data) 
+ SD (“at risk” sample). 
Separate binary logistic regression analyses were conducted to examine the 
effects of EDU, GAS, and their interaction on clinically significant change at post-
intervention and follow-up. Results were not significant for the effects of EDU, GAS, or 
their interaction on clinically significant change at post-intervention. Analyses revealed a 
significant GAS effect for clinically significant change at one-month follow-up (Wald 
X
2
(1) = 4.36, p = .04), suggesting that participants who received AIR demonstrated greater 
percentage of clinically significant change at follow-up. 
 




Anxiety Sensitivity Process Analyses 
Process analyses of each outcome variable examined the effects of EDU and GAS 
on change in anxiety sensitivity as well as its lower order subscales over time. For each 
outcome variable, separate 2-level HLM models examined changes in anxiety sensitivity 
and its three subscales over four time points (session 2, session 3, post-intervention, 
follow-up)  as a function of EDU, GAS and the interaction of these two intervention 
strategies. Anxiety sensitivity at session 1 was included as a covariate. 
 The level-1 model estimated within-subject change in outcomes as a function of 
time. Time
2
 was included as an additional level-1 variable to examine quadratic patterns 
of change. In the level-1 model, the rate of change was indicated by the slopes of Time 
and Time
2
; the outcome variable at session 2 was represented by the intercept. The level-
2 model examined whether the variation of regression coefficients for the level-1 
predictors were determined by the interaction of EDU and GAS, after controlling for the 
baseline level of the outcome variable.  
The Akaike information criterion (AIC) was used to determine which random 
effects to include in the final HLM model. After including the significant random effects, 
the fixed effects of each HLM model were examined. The full model included the 3-way 
interaction of EDU X GAS X Time
2
 and EDU X GAS X Time as well as their lower 
order terms. The model was condensed by removing non-significant terms in a backward 
stepwise fashion until only terms that were at least marginally significant remained.  
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Similar 2-level HLM analyses were conducted to examine whether baseline 
anxiety sensitivity and diagnostic status moderated the effects of EDU, GAS, or their 
interaction on changes in outcome variables over time. For each variable, the full model 
included the 4-way interactions of Moderator X EDU X GAS X Time
2
 and Moderator X 
EDU X GAS X Time as well as their lower order terms on reduction in anxiety 
sensitivity and its three subscales.  
Intervention Strategies on Anxiety Sensitivity Process 
The final models for the full scale of anxiety sensitivity as well as the social and 
cognitive subscales did not include significant effects of EDU, GAS, or their interaction. 
In contrast, the final model for the physical subscale included a marginally significant 
GAS X Time interaction (b= 1.35, t(273) = 1.91, p = .06) as well as a significant GAS X 
Time
2
 effect (b= -0.46, t(273) = -2.03, p = .04).  
Although both CO2 conditions and AIR conditions showed reductions in AS 
physical concerns over the intervention sessions, the CO2 conditions maintained 





Figure 3. Type of gas mixture on reduction in AS physical subscale 
 
Moderators for Anxiety Sensitivity Process 
Baseline Anxiety Sensitivity Moderates Anxiety Sensitivity Process 
    For the full scale of anxiety sensitivity, there was a marginally significant 
Baseline AS X GAS X EDU X Time interaction (b= .70, t(260) = 1.82, p = .07) and a 
significant Baseline S X GAS X EDU X Time
2
 interaction (b= -0.25, t(261) = -2.11, p = 
.04).  
When baseline anxiety sensitivity was severe, the H_Ed conditions continued to 
decrease over time points whereas the A_Ed conditions showed curvilinear changes. The 
A_Ed +AIR condition decreased in anxiety sensitivity over the intervention sessions, but 
did not fully maintain its reductions over the one-month follow-up period. The condition 
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that received both active intervention strategies (A_Ed + CO2) exhibited the fastest 
decrease in anxiety sensitivity (by session 1) and maintained these reductions over time.  
When baseline anxiety sensitivity was at the eligibility cutoff, all active 
conditions (i.e. all conditions that included either CO2 training or anxiety 
psychoeducation) decreased in anxiety sensitivity over intervention sessions and 
maintained these reductions over the follow-up period. Although the double placebo 
condition (H_Ed+AIR) also demonstrated reductions in anxiety sensitivity over the 





Figure 4. Reduction in anxiety sensitivity when baseline anxiety sensitivity is severe 
 
 




Baseline Anxiety Sensitivity Moderates AS Physical Concerns Process 
There was a marginally significant Baseline AS X GAS X EDU X Time
2
 
interaction for the AS physical subscale (b= -0.09, t(261) = -1.69, p = .10).  
The pattern of change for the AS physical concerns was similar to the interaction 
pattern found for anxiety sensitivity (i.e. full scale). When baseline anxiety sensitivity 
was severe, the H_Ed conditions displayed declines in AS physical concerns over the 
intervention sessions and maintenance of these reductions over the follow-up period. The 
A_Ed + AIR condition also demonstrated reductions in anxiety sensitivity over the 
intervention sessions but did not fully maintain these reductions over the follow-up 
period. Among the conditions, A_Ed+CO2 led to the fastest reductions in AS physical 
concerns and these reductions were maintained over time. 
When baseline anxiety sensitivity was at the eligibility cutoff, all active 
conditions decreased in anxiety sensitivity over intervention sessions and maintained 
reductions over the follow-up period. Although the double placebo condition 
(H_Ed+AIR) also demonstrated reductions in anxiety sensitivity over the intervention 





Figure 6. Reduction in physical subscale when baseline anxiety sensitivity is severe\ 
 
 
Figure 7. Reduction in physical subscale when baseline anxiety sensitivity is at eligibility 
cutoff 
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Baseline Anxiety Sensitivity Moderates AS Social Concerns Process 
 For the AS social subscale, there was a marginally significant Baseline AS X 
GAS X EDU X Time interaction (b= .31, t(261) = .18, p = .09) as well as a marginally 
significant Baseline AS X GAS X EDU X Time
2
 interaction (b= -0.11, t(261) = -1.98, p 
= .05).  
When baseline anxiety sensitivity was severe, the H_Ed conditions demonstrated 
reductions in AS social concerns after session 1 and maintained these reductions over the 
intervention period. In addition, H_Ed conditions displayed additional reductions in 
social concerns over the follow-up period. The A_Ed + AIR condition decreased in 
anxiety sensitivity over the intervention sessions but did not fully maintain these 
reductions over the follow-up period. Among the conditions, A_Ed+CO2 led to the 
fastest reductions in AS social concerns (by session 1) and these reductions were 
maintained through the follow-up. 
When baseline anxiety sensitivity was at the eligibility cutoff, the A_Ed 
conditions showed reductions in AS social concerns over time; the A_Ed+CO2 condition 
maintained its reductions over the follow-up period, while the A_Ed+AIR condition 
demonstrated additional reductions over the follow-up. The double placebo condition 
(H_Ed+AIR) also decreased in AS social concerns over the intervention sessions, but did 
not fully maintain these reductions over the follow-up period. Among the conditions, the 






Figure 8. Reduction in AS social concerns when baseline AS is severe 
 
 
Figure 9. Reduction in AS social concerns when baseline AS is at eligibility cutoff 
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Baseline Anxiety Sensitivity Moderates AS Cognitive Concerns Process 
For the cognitive subscale, there was a significant Baseline AS X EDU X Time
 
interaction (b = -.17, t(269) = -2.21, p = .03) as well as a Baseline AS X EDU X Time
2
 
interaction (b = .06, t(269) = 2.27, p = .02). Type of gas mixture was not a significant 
variable in the final model. 
When baseline anxiety sensitivity was severe, the H_Ed and A_Ed conditions led 
to rapid reductions in the cognitive subscale (after session 1). The A_Ed conditions 
demonstrated additional reductions over the intervention sessions, but did not fully 
maintain these reductions over the follow-up period. In contrast, the H_Ed conditions 
maintained their reductions from session 1 through the follow-up period. 
When baseline anxiety sensitivity was at the eligibility cutoff, the A_Ed 
conditions displayed the greatest reductions in AS cognitive concerns after session 1 and 
showed additional reductions over time. The H_Ed conditions displayed majority of their 






Figure 10. Reduction in cognitive subscale when baseline AS is severe 
 
 
Figure 11. Reduction  in cognitive subscale when baseline AS is at eligibility cutoff 
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Diagnostic Status Moderates Anxiety Sensitivity Process 
 For AS full scale, there was a significant Clinical Status X GAS X EDU X time
 
interaction (b= -7.00, t(219) = -2.91, p = .004).  
 When there was presence of an anxiety or mood diagnosis, all conditions 
decreased in anxiety sensitivity through post intervention. Over the follow-up period, the 
A_Ed+CO2 condition did not fully maintain its reductions while the other conditions 
exhibited maintenance of levels of anxiety sensitivity.  
When participants did not hold a current anxiety or mood diagnosis, all 
participants demonstrated a decrease in anxiety sensitivity over the intervention sessions. 
The A_Ed+CO2 condition led to the fastest reductions and maintained reductions over 
the follow-up period, while other conditions showed additional reductions throughout the 
intervention period. The A_Ed+AIR condition maintained reductions over the follow-up 
period, while the H_Ed+CO2 condition exhibited additional reductions over the follow-
up. In contrast, the double placebo (H_Ed+AIR) condition did not fully maintain 








Figure 13. Reduction in anxiety sensitivity when anxiety or mood diagnosis is not present  
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Diagnostic Status Moderates AS Physical Concerns Process 
Clinical status did not moderate the effects EDU, GAS, or their interaction on 
change in the AS social and AS cognitive subscales over time. For AS physical subscale, 
however, there was a Clinical Status X GAS X EDU X Time (b= -3.77, t(223) = -3.06, p 
= .002).  
When there was presence of a current anxiety or mood disorder, the A_Ed+CO2 
condition demonstrated reductions in physical concerns through the follow-up period. All 
other conditions did not fully maintain reductions shown from the intervention period at 
one-month follow-up. 
When participants did not hold a current anxiety or mood diagnosis, the A_Ed 
conditions showed reductions in AS physical concerns over intervention sessions and 
maintained these reductions over the follow-up period. The double placebo condition 
(H_Ed+AIR) also demonstrated reductions in AS physical concerns over the intervention 
sessions, but did not fully maintain these reductions over the follow-up period. Among 
the conditions, the H_Ed + CO2 condition displayed the least decline in physical 





Figure 14. Reduction in physical subscale when anxiety or mood diagnosis is present 
 
 
Figure 15. Reduction in physical subscale when anxiety or mood disorder is not present 
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Fear Habituation to Repeated Inhalations of Gas Mixture 
Separate 2-level HLM analyses were conducted to examine within-session and 
between-session habituation of fear response for the CO2 conditions and AIR conditions. 
Because reduction in anxiety sensitivity over time was moderated by baseline anxiety 
sensitivity and diagnostic status, these variables were examined as moderators for within-
session and between-session habituation as well. Therefore, separate analyses were 
conducted for each moderator and the full model examined Moderator X EDU X Session 
X Trial
2
 interaction on fear response to the gas mixture inhalation.  
Fear Habituation in CO2 conditions 
For CO2 conditions, neither diagnostic status nor baseline anxiety sensitivity 
moderated the effect of EDU on within-session or between-session fear habituation. The 
final model included a significant Baseline AS X Session interaction (b = -.41, t(725) = -
2.42, p =.02 and a significant Session X Trial
 
interaction (b = 1.99, t(725) = 5.98, p 
<.0001), suggesting that baseline anxiety sensitivity influenced within and between-
session fear habituation to repeated inhalations of gas mixture across CO2 conditions. 
There was greater between-session and within-session habituation of fear response to 
CO2 inhalations when baseline anxiety was severe than when baseline anxiety sensitivity 




Figure 16. Fear habituation in CO2 conditions when baseline AS is severe 
 





Fear Habituation in AIR Conditions 
Similar HLM analyses were conducted within AIR conditions. Clinical status did 
not moderate the effect of EDU on fear response to repeated inhalations of AIR. 
When baseline anxiety sensitivity was examined as a moderator, there was a 
significant EDU X Session X Trial interaction (b = 4.29, t(839) = 1.86, p = .02) and a 
marginally significant EDU X Session X Trial
2
 interaction predicting habituation in fear 
response to inhalations of AIR (b = -.67, t(839) = -1.88, p = .06).  
When baseline AS was severe, participants who received A_Ed showed greater 
fear habituation to repeated inhalations of AIR than participants who received H_Ed. On 
the other hand, those who received H_Ed showed greater between-session and within-
session habituation to the AIR training as compared to those who received A_Ed when 
















Figure 18. Fear Habituation in AIR conditions when baseline AS is severe 
 
 








 It was hypothesized that acceptance and distress tolerance would mediate the 
interactive effects of GAS X EDU on anxiety sensitivity. Therefore, separate mediation 
analyses were conducted examining whether the effect of GAS X EDU on anxiety 
sensitivity was mediated by acceptance and distress tolerance.  
Separate mediated moderation analyses were conducted for each subscale of 
acceptance (willingness, action) and distress tolerance (physical, emotional); the mediator 
variables were calculated by obtaining residualized scores at session 3 after controlling 
for baseline scores. Separate models were conducted with residualized anxiety sensitivity 
at post-intervention and follow-up intervention as outcome variables (after controlling for 
baseline anxiety sensitivity). 
 The indirect effect of the interaction of GAS X EDU, after controlling for main 
effects, on anxiety sensitivity (post-intervention, follow-up) through each of the mediator 
variables was examined using the methods described by Preacher and Hayes (2007). For 
each model, multiple regressions were conducted. The path coefficient from GAS X EDU 
to the mediator and the path coefficient from the mediator variable to outcome variable, 
was examined. For all examined models, the path coefficients were not significant. 
Therefore, mediation did not occur. 
POST-HOC POWER ANALYSIS  
In the current sample, the effect size for the observed interaction effect was .021 
based on the partial eta2 (which corresponds to f = .15). A post-hoc power analysis was 
conducted using the G*Power3 program, based on a repeated measure ANOVA model 
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that included the baseline and post-treatment (or follow-up) scores on the ASI-3. Given 
that α = .05, the average correlation among repeated measures was .59, and the total 






The overarching aim of the present study was to enhance knowledge of methods 
for reducing anxiety sensitivity, a dispositional variable consistently shown to be 
associated with anxiety disorders as well as other mental health problems. Toward this 
aim, the present randomized secondary prevention trial sought to examine strategies to 
reduce anxiety sensitivity among persons with elevated anxiety sensitivity by testing the 
singular and combined efficacy of two commonly used strategies in multi-component 
interventions for reducing anxiety sensitivity: (a) anxiety psychoeducation emphasizing 
the benign nature of stress, and (b) interoceptive exposure (i.e. repeated inhalations of 
35% CO2 gas mixture). 
Utilizing a 2 X 2 design, all participants received an education component and a 
component that included repeated inhalations of a gas mixture. To provide a stringent 
control for non-specific effects associated with anxiety psychoeducation (A_Ed) and 
interoceptive exposure with CO2 (CO2), two control strategies were included in the study 
design: general health and nutrition education (H_Ed) and repeated inhalations of regular 
room air (AIR).  
SELECTION OF ACTIVE INTERVENTION STRATEGIES 
 
Several factors guided the selection of anxiety psychoeducation and interoceptive 
exposure with CO2 for investigation in the current study. From a public health 
perspective, prevention programs should be easily disseminable, easily implemented, and 
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cost-efficient. Although many anxiety sensitivity reduction interventions have included 
multiple multimodal strategies (Alpblanalp, unpublished dissertation, Gardenswartz & 
Craske, 2001; Kenardy, McCafferty, & Rosa, 2003), more recent investigations have 
demonstrated that multicomponent interventions might not be necessary for the reduction 
of anxiety sensitivity (Schmidt, Eggleston, Woolaway-Bickel, Vasey, Richey, & 
Fitzpatrick, 2007, Smits, Rosenfield, Behar, Otto, and Powers, 2008). 
Anxiety psychoeducation has been commonly included in anxiety sensitivity 
reduction interventions in at risk populations and is easily disseminable. Interoceptive 
exposure is often touted as the most important strategy for anxiety sensitivity reduction in 
clinical settings, but it has not been examined as a singular strategy in at risk populations.  
Interoceptive exposure involves repeated exposure to feared physiological 
sensations until fear is habituated or extinguished. Interoceptive exposure with CO2 has 
been investigated as an effective treatment strategy for patients with panic disorder (Griez 
and Van den Hout, 1986; Van den Hout, Van der Molen, Griez, & Lousberg, 1987), but it 
has not been tested as an intervention strategy within at risk populations. Because the 
inhalation of CO2 has been shown to consistently elicit fear response among individuals 
with high anxiety sensitivity (Harrington, Schmidt & Telch; 1996; Zvolensky et al., 1997, 
1999), it was predicted that interoceptive exposure with CO2 would serve as an optimal 
interoceptive exposure strategy for this at risk population. 
CLINICAL EFFICACY 
Contrary to predictions, the primary indices of anxiety sensitivity reduction at 
post-intervention were not significantly affected by type of gas mixture, type of 
 83 
education, or their interaction. Despite the lack of between-condition effects, all 
conditions showed significant reductions in indices of anxiety sensitivity including the 
ASI-3 full scale and its lower order subscales, fear of bodily sensations as indexed by the 
BSQ, and subjective fear in response to a voluntary hyperventilation challenge. Taken 
together, these data indicate that anxiety sensitivity was significantly reduced in all 
conditions. 
The pre- to post-intervention within-group Cohen‟s effect sizes were large in all 
conditions, ranging from .80 to 1.43. The within-group effect sizes from the present study 
are comparable to those reported in the eight previously published intervention trials for 
anxiety sensitivity reduction reported by Smits et al. (2008). In their meta-analysis, the 
pre- to post-intervention effect size (Cohen‟s d) for the active intervention groups was 
1.03, while the within-condition effect size for the control groups (i.e. psychological 
placebo or wait-list control) was .65. Therefore, all conditions in the present study 
exhibited similar effect sizes in comparison to the large effect size found for the 
intervention groups from the Smits et al. (2008) meta-analysis. 
At follow-up, all conditions showed significant reductions in anxiety sensitivity 
from pre-intervention as well. The within-group effect sizes at follow-up remained large, 
ranging from .77 to 1.16 (Cohen‟s d). Similar to findings for post-intervention, most 
primary indices of anxiety sensitivity were not significantly affected by type of gas 
mixture, type of education, or their interaction. Although there were no differential 
effects for continuous measures of anxiety sensitivity at follow-up, participants who 
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received AIR were more likely to achieve clinically significant reductions in anxiety 
sensitivity as compared to participants in CO2 conditions at follow-up.  
The finding that all conditions showed within group reductions of a magnitude 
greater than that reported for the control groups in previous studies at post-intervention 
and follow-up suggests that all conditions in the present study demonstrated meaningful 
reductions in anxiety sensitivity. 
WHY WAS THERE NO SUPPORT FOR ACTIVE INTERVENTIONS? 
Intervention Manipulation Failure 
When differential effects are not fully supported, it is important to consider the 
effectiveness of manipulation strategies. With regard to the education manipulation, 
participants watched power-point videos that were previously used in other studies 
(Schmidt et al., 2007; Feldner et al., 2008). These videos were matched for time and 
general education, and it was ensured that the health education did not address anxiety or 
fear of physical sensations. Finally, the videos were administered by undergraduate 
research assistants who were present while participants watched the videos. 
For the inhalation of gas mixture, participants who received CO2 reported greater 
intensity of sensations to the inhalation of gas mixture as compared to participants who 
received AIR. This suggests that the gas mixtures were effectively administered and that 
the CO2 gas mixture produced intense physiological effects. Taken together, it can be 
assumed that the manipulations were implemented with integrity. 
Regression to the Mean 
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In the absence of a wait-list control, regression to the mean remains a rival 
hypothesis to account for the reductions observed from pre-to post-intervention. 
Although possible, several methodological features of the present study render it unlikely 
that regression to the mean was responsible for the significant reductions observed from 
pre-to post-intervention. Specifically, an anxiety sensitivity stability inclusion criterion 
was imposed such that participants were required to display elevated anxiety sensitivity 
on two consecutive occasions prior to entering into the study. This criterion resulted in 
the exclusion of approximately 50% of the screening sample.  
Nonspecific vs. Common Factors 
The large magnitudes of within-condition effects suggest that it is unlikely that 
the reductions in anxiety sensitivity were accounted for by nonspecific factors, such as 
reassurance or support provided by research assistants. It is plausible that the within-
condition effects were due to common factors that were not intended to cause significant 
reductions in anxiety sensitivity. For example, Maltby, Mayers, Allen and Tolin (2005) 
demonstrated that anxiety sensitivity was significantly reduced among persons with high 
anxiety sensitivity following diagnostic structured interview, even when no intervention 
for anxiety sensitivity reduction was administered. There were no differences in the 
reduction shown in anxiety sensitivity between participants who received an intervention 
following the diagnostic interview and those who did not receive an intervention, 
however, participants who did not receive a structured clinical interview showed 
negligible reductions in anxiety sensitivity. 
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Maltby, Mayers, Allen, and Tolin (2005) argued that the significant reductions 
demonstrated by groups that received structured clinical interviews might have resulted 
from normalizing information regarding physical, social and cognitive concerns. The 
present study included several common factors across conditions that might have affected 
anxiety sensitivity, including structured diagnostic interviews and behavioral challenge 
assessments. Therefore, the possibility that such common factors might have contributed 
to the observed reductions in anxiety sensitivity cannot be ruled out. 
“Control” Strategies as “Active” Strategies 
An alternative explanation for the null effects is that the intended control 
intervention strategies might have functioned as active intervention strategies. With 
regard to education, it is unlikely that the health education had an active effect on anxiety 
sensitivity reduction. The health education that was administered in the present study was 
used in previous studies as a stand-alone control intervention, and this intervention did 
not lead to significant within-condition reductions in those studies (Schmidt et a1., 2007, 
Feldner et al., 2008).  
A novel component of this study was the inclusion of exposure sessions with 
breathing air (AIR) as a control strategy for interoceptive exposure with CO2. The 
procedure was identical to the procedure for interoceptive exposure with CO2, with the 
only manipulated variable being the contents of the gas mixture. Although it was 
intended as a control strategy, repeated inhalations of breathing air might have had a 
specific effect on anxiety sensitivity that was not predicted. In fact, findings 
demonstrating that participants who received repeated inhalations of AIR were more 
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likely to achieve clinically significant change than participants who received 
interoceptive exposure with CO2 suggest that this strategy that was intended as a placebo 
might have been a more effective strategy. For example, the process of repeated trials of 
breathing full-vital capacity inhalations of regular room air might have functioned as a 
deep breathing exercise and reduced anxiety sensitivity by promoting relaxation. 
Participants in all conditions were presented with the rationale for interoceptive 
exposure and were told that they would be inhaling a gas mixture that might elicit some 
uncomfortable physiological sensations. Perhaps the experience of undergoing this 
procedure and not experiencing expected uncomfortable sensations led to increased self-
efficacy. 
The repeated inhalation of regular room air was not intended to elicit fear 
response, however, it is plausible that the repeated inhalations of AIR might have 
functioned as an exposure exercise for non-interoceptive fears. Even though the regular 
room air did not produce “interoceptive” changes, the overall procedure of repeated 
inhalations of an unknown gas mixture might have activated fears that are relevant to 
anxiety sensitivity (i.e. physical, social and cognitive concerns).  
Null Effects for Fear Response to Behavioral Challenges 
It is unexpected that there was not an overall effect of type of gas mixture for fear 
response to behavioral challenges. It was predicted that interoceptive exposure with CO2 
would have a stronger effect on diminishing fear response to the behavioral challenges 
because of the conceptual match between the specific effects of the intervention strategy 
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(i.e. repeated exposure to uncomfortable physiological sensations) and the modality of 
assessment (i.e. behavioral challenge that elicits uncomfortable physiological sensations).  
The null effect between repeated inhalations of CO2 and AIR is particularly 
surprising for fear response to the CO2 challenge at post-intervention and follow-up. For 
those who had received interoceptive exposure with CO2 during the intervention sessions, 
the CO2 challenge was no different than the context in which they were trained whereas 
those who had received AIR during intervention sessions underwent a CO2 inhalation for 
the first time. This null effect suggests that the actual contents of the gas mixture had 
little influence on fear response to the behavioral challenges. 
Rather, the null findings support that the effects of the repeated inhalations of gas 
mixture were more likely due to common factors shared across the strategies rather than 
the specific physiological effects produced by the contents of the gas. It is likely that the 
context of the situation (i.e. repeated inhalations of an unknown gas) might have led to 
similar reductions in fear response to the behavioral challenges, regardless of the actual 
gas mixture. This is consistent with findings from the fear provocation literature that 
demonstrate that contextual variables such as perceived safety, perceived control, and 
expectancies influence fear response to biological challenges (Carter, Hollon, Carson, & 
Shelton, 1995; Sanderson, Rapee, & Barlow, 1989; Telch, Silverman, and Schmidt, 1996; 
Telch, Smits, Brown, Powers, Lee & Pai, 2010; Zvolensky et al., 1997, 1999). 
Related Psychological Dispositions 
 There were significant within-condition reductions for other psychological 
measures that are related to anxiety sensitivity as well (i.e. trait anxiety, depression). In 
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fact, within-condition reductions for depression symptoms and fear of bodily sensations 
from pre-intervention to post-intervention as well as pre-intervention to follow-up had 
large effect sizes. Therefore, the effects of the interventions tested in the current study 
were not specific to anxiety sensitivity. 
 This finding suggests that there might have been common factors associated with 
these interventions that affected multiple psychological dispositions. Perhaps the 
normalizing information provided by structured clinical diagnostic interviews influenced 
reduction in depression symptoms as well. Alternatively, more general factors such as 
demand characteristics or expectancies might have led to substantial reductions in all 
psychological variables. 
 An alternative explanation for the reduction in depression symptoms could be that 
the reductions in anxiety sensitivity led to subsequent reductions in mood symptoms. For 
example, Smits et al. (2008) demonstrated that reductions in anxiety sensitivity with 
exercise mediated the effects of exercise on depression symptoms. Depression symptoms 
were not assessed during intervention sessions in the present study, but it is possible that 
the rapid reductions in anxiety sensitivity during the intervention session subsequently 
led to reductions in mood symptoms. 
PROCESS ANALYSES  
 
Patterns of Change 
Although there were no differential effects of intervention strategies at post-
intervention or follow-up, there were between-condition differences when examining 
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patterns of reductions in anxiety sensitivity and its subscales over the intervention period 
and follow-up. There were no significant effects of intervention strategies on change in 
anxiety sensitivity overall, however, differential effects of intervention strategies 
emerged when examined in the context of moderator variables (i.e. baseline anxiety 
sensitivity, clinical status). 
Two consistent findings were demonstrated. First, the group that received both 
active intervention strategies (A_Ed+CO2) showed the fastest reductions in anxiety 
sensitivity and maintained reductions through the follow-up period when baseline anxiety 
sensitivity was severe. Therefore, for those most “at risk,” the combination of anxiety 
psychoeducation and interoceptive exposure with CO2 might have been the optimal 
intervention strategy. 
Second, the double placebo condition (H_Ed+AIR) did not fully maintain 
reductions from the intervention period over the one month follow-up when baseline 
anxiety sensitivity scores were at the cutoff for eligibility requirements for this study. 
Therefore, for those with milder severity there is evidence that the double placebo 
condition might not maintain stability of reductions in anxiety sensitivity over time. 
Patterns of Fear Response During Inhalation Sessions 
Consistent with hypotheses, process analyses demonstrated that interoceptive 
exposure with CO2 led to within-session and between-session habituation. In two case 
studies examining patterns of fear response, Beck and colleagues (Beck, Shipherd, & 
Read, 1999; Beck & Wolf, 2001) examined individual patterns of fear reduction to 12 
trials of CO2 inhalations. To reduce expectancy effects, participants were told that the 
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experiment involved the investigation of respiratory control.  Participants varied in their 
individual patterns of fear responding to CO2 inhalations over time. When exposed to 
35% CO2 inhalations, 37% of individuals demonstrated habituation, 47% demonstrated 
sensitization, and 16% remained stable (Beck et al., 1999). In a replication study with 
20% CO2 gas inhalations, a greater proportion of individuals displayed habituation, with 
67% of participants classified as habituators and 33% classified as nonhabituators (Beck 
& Wolf, 2001). In the present study, there were no sensitizers when examining patterns 
of fear response. The difference between fear response patterns in the current study as 
compared to the previously mentioned studies suggests that the habituation response to 
interoceptive exposure with CO2 was partly driven by expectancies produced by the 
intervention rationale. 
Contrary to predictions, the AIR conditions showed between-session and within-
session habituation as well. Repeated inhalation of AIR was intended as a placebo control 
for interoceptive exposure with CO2. Although participants were told that the gas mixture 
they were to inhale might elicit some uncomfortable physiological sensations, it was 
anticipated that any fear elicited by this task would extinguish once participants received 
the inhalation of a benign gas mixture. The patterns of fear response suggest that fear was 
activated and reductions followed a pattern of habituation; this fear response pattern 
suggests that repeated inhalations of AIR might have functioned as a fear exposure 
exercise. As the actual contents of the gas mixture produced no physiological effects, the 
pattern of fear response in conditions that received AIR was most likely a function of the 
context of the situation.  
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Mechanisms of Change 
 Indices of severity (i.e. baseline anxiety and presence of anxiety or mood 
disorder) were chosen as putative moderators of intervention effects. It was hypothesized 
that these variables would increase the effects of the superiority of the active intervention 
strategies over the control strategies. Attempts to identify moderators of anxiety 
sensitivity reduction were unsuccessful. Neither baseline anxiety nor diagnostic status 
interacted with intervention strategies to predict anxiety sensitivity reduction. 
Acceptance and distress tolerance were chosen as potential mediators because of 
their relevance to models of fear reduction for interoceptive exposure. These variables 
did not mediate effects of active intervention strategies on reduction in anxiety 
sensitivity. 
IMPLICATIONS  
The present study did not support the efficacy of the hypothesized active 
intervention strategies (i.e. anxiety psychoeducation and interoceptive exposure with 
CO2) in comparison to the placebo control intervention strategies (i.e. health education 
and repeated inhalations of regular room air). Rather, all conditions led to significant 
reductions in anxiety sensitivity scores that were comparable to effect sizes of active 
interventions in previous randomized prevention studies. In addition, all conditions led to 
significant differences in indices related anxiety sensitivity, such as fear of bodily 
sensations and fear response to behavioral challenges. Consistent with previous anxiety 
sensitivity reduction studies (e.g. Feldner et al., 2008; Schmidt et al., 2007) the present 
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investigation showed that anxiety sensitivity was significantly reduced following brief 
interventions (i.e. 3 intervention sessions). 
The current study also has implications for the dissemination of prevention 
programs. The interventions were administered by undergraduate research assistants and 
did not require highly trained psychology staff. In addition, the education component was 
delivered via computer which ultimately could be administered at home. Therefore, it is 
feasible for this type of intervention program to be easily disseminated in a variety of 
settings. 
Findings from the present study also support that brief interventions aimed at 
reducing anxiety sensitivity might reduce risk for psychopathology. Atlhough a long-term 
follow-up was not included in the present study, reductions in anxiety sensitivity 
demonstrated in the current study are comparable to reductions in other prevention 
studies in which anxiety sensitivity reductions following brief prevention interventions 
were lasting (e.g. Abplanalp, unpublished dissertation; Gardenswartz & Craske, 2001). 
The reductions in anxiety sensitivity are also comparable to other reductions seen in other 
prevention studies in which interventions reduced risk for future psychopathology (e.g. 
Gardenswartz & Craske, 2001; Schmidt et al, 2007). 
The examined interventions in the present study led to significant declines in 
psychological dispositions (e.g. depression symptoms) that are related to anxiety 
sensitivity as well, suggesting that these interventions that were designed to reduce 
anxiety sensitivity might have generalized to various psychological dispositions. 
Although the stability of these reductions over a long-term follow-up cannot be 
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determined in the present study, these findings are promising from a prevention 
standpoint as the interventions might not only target one risk factor (e.g. anxiety 
sensitivity) but might decrease multiple risk factors for the development and maintenance 
of psychopathology. 
Findings from the present study have implications for methodological 
considerations for secondary prevention studies as well. All of the conditions in the 
present study showed greater within-condition effects than wait-list controls and 
psychological placebo controls in other studies. Relative to stringent controls, there was 
no support for the efficacy of the hypothesized active intervention strategies of anxiety 
psychoeducation and interoceptive exposure with CO2.  
Based on a meta-analytic review of eight studies examining interventions for 
anxiety sensitivity reduction in at risk populations, Smits, Berry, Tart, and Powers (2008) 
concluded that randomized intervention trials offer “sound support” for the efficacy of 
CBT in reducing anxiety sensitivity in at risk populations. Findings from the present 
study suggest that research to date have failed to provide stringent tests of CBT 
intervention strategies; the absence of stringent control conditions might have led 
researchers to prematurely conclude that the efficacies of tested interventions are related 
to the "active" effects of these strategies when the interventions might be capitalizing on 
common factors. 
 Among the anxiety sensitivity reduction studies in at risk populations, 
approximately one half of them have included wait-list control conditions (i.e. 
Gardenswartz & Craske, 2001; Broman-Fulks & Storey, 2008; Kenardy et al., 2003, 
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Maltby, unpublished dissertation; Smits et al., 2008) Of the five studies that included 
wait-list control groups, only two randomized prevention trials demonstrated significant 
differences between the experimental condition and a wait-list condition in the reduction 
of anxiety sensitivity (Broman-Fulks et al., 2008; Smits et al., 2008). Both studies 
demonstrated the efficacy of aerobic exercise for the reduction of anxiety sensitivity, 
however, the experimental design employed in these studies cannot rule out that a large 
part of the effects of these experimental conditions might have been a result of time spent 
with research assistants, expectancy, or other simple factors.  
Among the previous prevention studies that have utilized psychological placebo 
control conditions, three of the four have demonstrated efficacy for CBT programs 
relative to non-specific controls at post-intervention (Abplanalp, unpublished 
dissertation; Feldner et al., 2008; Schmidt et al, 2008). For example, Apblanalp 
(unpublished dissertation) demonstrated the efficacy of a CBT package including anxiety 
pscychoeducation, interoceptive exposure, and breathing retraining compared to an 
ethics-based education program on the reduction of anxiety sensitivity; these reductions 
were stable at 1-yr follow-up. In two separate studies, Schmidt et al. (2007) and Feldner 
et al. (2008) demonstrated that the effects of anxiety psychoeducation and interoceptive 
exposure led to greater reductions in anxiety sensitivity than a health education control at 
post-intervention, however, the group differences were not fully maintained over a long-
term follow-up. In an investigation of the effects of high intensity aerobic exercise on the 
reduction of anxiety sensitivity, a stringent placebo control (i.e. low intensity exercise) 
was employed. Although the high aerobic exercise led to faster declines, there were no 
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differences between anxiety sensitivity scores between the two groups at post-
intervention. Thus, while the studies that have included psychological placebo conditions 
provided overall support for the efficacy of the tested interventions, the necessity of 
specific CBT strategies for the reduction of anxiety sensitivity remains unclear.  
Most of the randomized intervention trials aimed at reducing anxiety sensitivity in 
at risk populations have tested CBT intervention strategies or aerobic exercise 
interventions, with an assumption that exposure to physiological sensations that resemble 
anxiety-related sensations are beneficial to the reduction of anxiety sensitivity. While 
some of these intervention strategies might be passive (e.g. anxiety psychoeducation), 
other strategies might require time, effort, courage, or endurance of uncomfortable 
feelings (e.g. interoceptive exposure, aerobic exercise). The present study demonstrated 
that in the presence of a stringent control, active intervention strategies did not provide 
additional benefit. This raises the question, are the intervention strategies that have been 
presumed to be efficacious actually necessary? 
In the present study, the double placebo condition led to significant reduction in 
anxiety sensitivity. In fact, participants who received repeated inhalations of AIR were 
more likely to achieve clinically significant reductions in anxiety sensitivity at follow-up 
as compared participants who received interoceptive exposure with CO2. Although the 
difference was not statistically significant, there was also less dropout in the AIR groups 
than the CO2 conditions. The results demonstrating that the double placebo condition led 
to similar reductions, if not greater reductions, in anxiety sensitivity as compared to more 
aversive intervention strategies provides evidence to refute the assumption that 
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intervention strategies that are employed in treatment protocols for anxiety disorders are 
necessarily optimal strategies for reduction of anxiety sensitivity in the at risk population. 
Despite the general null effects between groups, the differences in patterns of 
decline in anxiety sensitivity over time suggest that the hypothesized active intervention 
strategies might be particularly useful under certain conditions. For example, individuals 
with the highest anxiety sensitivity that received both anxiety psychoeducation and 
interoceptive exposure with CO2 showed the fastest reductions (after session 1) and 
maintained these reductions over time. Thus, this type of “active” intervention might not 
require the full number of sessions and therefore might be considered an optimal 
intervention for those who are most at risk. 
LIMITATIONS  
 Several limitations of the present study are worth mention. Findings from the 
present study suggest that the observed anxiety sensitivity reductions were accounted for 
by factors unrelated to the hypothesized active interventions or their combination. In the 
absence of a no treatment control, the relevant factors that led to significant reductions in 
the double placebo condition cannot be elucidated. Similarly, certain factors that might 
have been relevant to the efficacy of the control strategies (e.g. relaxation, self-efficacy) 
were not assessed. 
Although the finding that participants demonstrated significant reductions in 
anxiety sensitivity from pre-intervention to one-month follow-up following a brief 
intervention is promising, this brief follow-up period limits the prediction of stability of 
anxiety sensitivity over time.  
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The sample consisted mostly of undergraduate students and did not represent 
individuals with high anxiety sensitivity in the general population. Although this limits 
the generalizability of the present study, it is relevant to secondary prevention programs. 
Undergraduate university settings are an ideal setting in which to implement secondary 
prevention programs as universities have the resources to implement programming that is 
easily accessible to its students. 
IMPLICATIONS FOR FUTURE RESEARCH  
 
 Given that anxiety sensitivity might be easily malleable following simple 
strategies, future research should examine basic interventions. Future secondary 
prevention intervention studies should investigate brief, cost-efficient, and palatable 
strategies in order to develop interventions that would be most easily disseminated and 
accepted. 
Although investigation of simple interventions would be useful, it is also 
important to investigate strategies to increase the effectiveness of anxiety sensitivity 
reductions. While most participants in the present study showed significant reductions in 
anxiety, the means of conditions at post-intervention and follow-up remained in the 
“risk” zone. In addition, the percentage of participants who achieved clinically significant 
change in the present study was modest. 
As the ultimate goal of reducing anxiety sensitivity in at-risk populations is to 
reduce risk for psychopathology, longitudinal follow-up studies should be conducted to 
determine whether the effects on anxiety sensitivity as well as other psychological 
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measures that are relevant to the development of psychopathology (e.g. depression 
symptoms) are lasting. In addition, examining change in psychopathology (e.g. incidence, 
remission, levels of severity) would confirm whether these reductions contributed to 
reduced risk for future psychopathology. 
 Finally, future randomized prevention trials for the reduction of anxiety 
sensitivity in at-risk samples should employ stringent experimental controls. More 
stringent control conditions are necessary in order to adequately test the specific effects 
of active interventions on the reduction of anxiety sensitivity and to enhance knowledge 





1. Demographic Questionnaire 
2. Medical History Questionnaire (MHQ) 
3. Anxiety Sensitivity Index-3 (ASI-3) 
4. Body Sensations Questionnaire (BSQ) 
5. Behavioral Task Forms 
6. State-Trait Anxiety Inventory-Trait subscale (STAI-T) 
7. Beck Depression Inventory- II (BDI-II) 
8. Brief Fear of Negative Evaluation (BNFE) 
9. Interoceptive Exposure Process Measure 
10. Acute Panic Inventory (API) 
11. Acceptance and Action Questionnaire (AAQ-9) 
12. Distress Tolerance Inventory (DTI) 
13. Credibility/Expectancy Questionnaire (CEQ) 










Gender: Male  /  Female 
  
Predominant Ethnicity:   ___Black (not Hispanic)  
  
___White (not Hispanic)           ___Hispanic      
  
___Asian or Pacific Islander     ___American Indian or Alaskan Native 
  
Other (please specify):______________________ 
  
Semesters of college completed:            ___________ 
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Medical History Questionnaire 
 
Please indicate whether you are experiencing or have experienced the following 
conditions by circling “yes” or “no.” 
 
Cardiovascular disorder (e.g. cardiac arrythmia, cardiac failure) Yes No 
 
Respiratory disorder (e.g. asthma, lung fibrosis)   Yes  No 
 
High blood pressure       Yes No 
 
Epilepsy        Yes No 
 
Stroke         Yes No 
 
Seizures        Yes No 
Have you ever experienced a panic attack? (a panic attack  
is a sudden rush of fear and urge to flee, along with  
symptoms such as increased heart rate, sweating, or dizziness) Yes No 
Have you taken psychotropic medication during the  
past two weeks?        Yes No 
For females: 
Are you currently pregnant or lactating?    Yes No 
 





Please circle the number that best corresponds to how much you agree with each item. If 
any items concern something that you have never experienced (e.g., fainting in public) 
answer on the basis of how you think you might feel if you had such an experience. 
Otherwise, answer all items on the basis of your own experience. Be careful to circle only 












1. It is important for me not to appear nervous. 0 1 2 3 4 
2. When I cannot keep my mind on a task, I worry that I 
might be going crazy. 
0 1 2 3 4 
 
3. It scares me when my heart beats rapidly. 0 1 2 3 4 
4. When my stomach is upset, I worry that I might be 
seriously ill.  
0 1 2 3 4 
5. It scares me when I am unable to keep my mind on a 
task. 
0 1 2 3 4 
6. When I tremble in the presence of others, I fear what 
people might think of me.  
0 1 2 3 4 
 
7. When my chest feels tight, I get scared that I won‟t be 
able to breathe properly.  
0 1 2 3 4 
 
8. When I feel pain in my chest, I worry that I am going to 
have a heart attack.  
0 1 2 3 4 
 
9. I worry that other people will notice my anxiety.  0 1 2 3 4 
10. When I feel “spacey” or spaced out I worry that I may 
be mentally ill.  
0 1 2 3 4 
 
11. It scares me when I blush in front of people.  0 1 2 3 4 
12. When I notice my heart skipping a beat, I worry that 
there is something seriously wrong with me.  
0 1 2 3. 4 
 
13. When I begin to sweat in a social situation, I fear people 
will think negatively of me.  
0 1 2 3 4 
 
14. When my thoughts seem to speed up, I worry that I 
might be going crazy.  
0 1 2 3 4 
 
15. When my throat feels tight, I worry that I could choke to 
death.  
0 1 2 3 4 
 
16. When I have trouble thinking clearly, I worry that there 
is something wrong with me.  
0 1 2 3 4 
 
17. I think it would be horrible for me to faint in public. 0 1 2 3 4 
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18. When my mind goes blank, I worry there is something 
terribly wrong with me.  







Please indicate the degree to which you find the following body sensations distressing when you 
are anxious.  Rate the degree to which these feelings are troubling by using the following scale.  
Write your score in the blank next to each sensation described. 
 1.  Not frightened or worried by this sensation when I am anxious. 
 2.  Rarely frightened or worried by this sensation when I am anxious. 
 3.  Frightened by this sensation about half the time when I am anxious. 
 4.  Frightened by this sensation most of the time when I am anxious. 
 5.  Extremely frightened by this sensation when I am anxious. 
_____  Heart palpitations 
_____  Pressure in chest 
_____  Numbness in arms or legs   
_____  Tingling in fingertips 
_____  Numbness in another part of your body  
 (please name that part:_________________) 
_____  Feeling short of breath 
_____  Dizziness 
_____  Blurred or distorted vision 
_____  Nausea 
_____  Butterflies in stomach 
_____  Knot in stomach 
_____  Lump in throat 
_____  Wobbly or rubber legs 
_____  Sweating 
_____  Dry throat 
_____  Feeling disoriented and confused 





I will be taking you through a rapid breathing procedure. This procedure will involve having you 
breathe for a period of 2 minutes at a significantly accelerated pace, approximately three times the 
rate you normally breathe.  
 
Demonstrate this for participant. 
Have the participant model it back for you. 
 
We are about to start the hyperventilation exercise. 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, what is the HIGHEST level of fear you expect to experience at any time 
during the hyperventilation exercise? 
 
            0 10 20 30 40 50 60 70 80 90 100 




1. What is the HIGHEST level of fear you experienced at any time during the hyperventilation 
exercise? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the hyperventilation exercise, did you panic?   Yes 
 No 
 
3. At any point during the hyperventilation exercise, did you have the urge to flee?  Yes 
 No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 
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      Straw-breathing  Form 
 
For the next challenge, I will ask you to breathe through a coffee straw. Please pinch your 
nose so that you can only breathe through your mouth. You should then breathe through 
the straw until I ask you to stop. 
 
We are about to start the straw-breathing exercise. 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the straw-breathing exercise? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 




1. What is the HIGHEST level of fear you experienced at any time during the straw-breathing exercise? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the straw-breathing exercise, did you panic?   Yes 
 No 
 
3. At any point during the straw-breathing exercise, did you have the urge to flee?  Yes 
 No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed  
       
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed  
   
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed  
   
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed  
   
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed  
   
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed  
   
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 









For the next challenge, I will spin you in this swivel chair. 
 
We are about to start the spinning exercise. 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the spinning exercise? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 




1. What is the HIGHEST level of fear you experienced at any time during the spinning exercise? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the spinning exercise, did you panic?   Yes 
 No 
 
3. At any point during the spinning exercise, did you have the urge to flee?  Yes 
 No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 





Instructions: A number of statements which people have used to describe themselves are given below.  Read 
each statement carefully and respond to it by writing down a number between 1 and 4 next to each statement.  Use 
the number that best indicates that best indicates how you generally feel.  There are no right or wrong answers.  
Do not spend too much time on any one statement but give the answer that seems to describe you generally feel.  
The possible ratings are presented in the scale below. 
1 = Almost never  2 = Sometimes 
3 = Often   4 = Almost always 
1.  I feel pleasant.      1 2 3 4  
2.  I feel nervous and restless.     1 2 3 4 
3.  I feel satisfied with myself.    1 2 3 4 
4.  I wish I could be as happy as others seem to be.  1 2 3 4 
5.  I feel like a failure.      1 2 3 4 
6.  I feel rested.       1 2 3 4 
7.  I am “calm, cool, and collected.”    1 2 3 4 
8.  I feel that difficulties are piling up so that I cannot  
overcome them.       1 2 3 4 
9.  I worry too much over something that really  
does not matter.       1 2 3 4 
10.I am happy.       1 2 3 4 
11. I have disturbing thoughts.     1 2 3 4 
12. I lack self-confidence.     1 2 3 4 
13. I feel secure.      1 2 3 4 
14. I make decisions easily.     1 2 3 4 
15. I feel inadequate.      1 2 3 4 
16. I am content.      1 2 3 4 
17. Some unimportant thought runs through my    
mind and bothers me.      1 2 3 4 
18. I take disappointments so keenly that I can’t put  
them out of my mind.      1 2 3 4 
19. I am a steady person.     1 2 3 4 
20. I get in a state of tension or turmoil as I think over 




The following 21 questions measures recent symptoms of depression. Please read each 
group of statement carefully, and then circle the one statement in each group that best 
describes the way you have been feeling during the past two weeks, including today.  
 
1. Sadness 
I do not feel sad. 
I feel sad much of the time. 
I am sad all the time. 
I am so sad or unhappy that I can't stand it. 
 
2. Pessimism 
I am not discouraged about my future. 
I feel more discouraged about my future than I used to be. 
I do not expect things to work out for me. 
I feel my future is hopeless and will only get worse. 
 
3. Past Failure 
I do not feel like a failure. 
I have failed more than I should have. 
As I look back, I see a lot of failures. 
I feel I am a total failure as a person. 
 
4. Loss of Pleasure 
I get as much pleasure as I ever did from the things I enjoy. 
I don't enjoy things as much as I used to. 
I get very little pleasure from the things I used to enjoy. 
I can't get any pleasure from the things I used to enjoy. 
 
5. Guilty Feelings 
I don't feel particularly guilty. 
I feel guilty over many things I have done or should have done. 
I feel quite guilty most of the time. 
I feel guilty all of the time. 
 
6. Punishment Feelings 
I don't feel I am being punished. 
I feel I may be punished. 
I expect to be punished. 
I feel I am being punished. 
 
7. Self-Dislike 
I feel the same about myself as ever. 
I have lost confidence in myself. 
I am disappointed in myself. 




I don't criticize or blame myself more than usual. 
I am more critical of myself than I used to be. 
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I criticize myself for all of my faults. 
I blame myself for everything bad that happens. 
 
9. Suicidal Thoughts or Wishes 
I don't have any thoughts of killing myself. 
I have thoughts of killing myself, but I would not carry them out. 
I would like to kill myself. 
I would kill myself if I had the chance. 
 
10. Crying 
I don't cry any more than I used to. 
I cry more than I used to. 
I cry over every little thing. 
I feel like crying, but I can't. 
 
11. Agitation 
I am no more restless or wound up than usual. 
I feel more restless or wound up than usual. 
I am so restless or agitated that it's hard to stay still. 
I am so restless or agitated that I have to keep moving or doing something. 
 
12. Loss of Interest 
I have not lost interest in other people or activities. 
I am less interested in other people or thins than before. 
I have lost most of my interest in other people or things. 
It's hard to get interested in anything. 
 
13. Indecisiveness 
I make decisions about as well as ever. 
I find it more difficult to make decisions than usual.. 
I have much greater difficulty in making decisions than I used to.. 
I have trouble making any decisions. 
 
14. Worthlessness 
I do not feel I am worthless.. 
I don't consider myself as worthwhile and useful as I used to.. 
I feel more worthless as compared to other people.. 
I feel utterly worthless. 
 
15. Loss of Energy 
I have as much energy as ever. 
I have less energy than I used to have. 
I don't have enough energy to do very much. 
I don't have enough energy to do anything. 
 
16. Changes in Sleeping Pattern 
I have not experienced any change in my sleeping pattern.. 
---------------------------------------------------------------- 
I sleep somewhat more than usual. (OR) 
I sleep somewhat less than usual. 
---------------------------------------------------------------- 
I sleep a lot more than usual. (OR) 
I sleep a lot less than usual. 
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---------------------------------------------------------------- 
I sleep most of the day (OR) 
I wake up 1-2 hours early and can't get back to sleep. 
 
17. Irritability 
I am no more irritable than usual. 
I am more irritable than usual. 
I am much more irritable than usual. 
I am irritable all the time. 
 
18. Changes in Appetite 
I have not experienced any change in my appetite. 
---------------------------------------------------------  
My appetite is somewhat less than usual. 
My appetite is somewhat greater than usual. 
---------------------------------------------------------  
My appetite is much less than before. 
My appetite is much greater than usual. 
--------------------------------------------------------- 
I have no appetite at all. 
I crave food all the time. 
 
19. Concentration Difficulty 
I can concentrate as well as ever. 
I can't concentrate as well as usual. 
It's hard to keep my mind on anything for very long. 
I find I can't concentrate on anything. 
 
20. Tiredness or Fatigue 
I am no more tired or fatigued than usual. 
I get more tired or fatigued more easily than usual. 
I am too tired or fatigued to do a lot of the things I used to do. 
I am too tired or fatigued to do most of the things I used to do. 
 
21. Loss of Interest in Sex 
I have not noticed any recent change in my interest in sex. 
I am less interested in sex than I used to be. 
I am much less interested in sex now. 






This section is concerned with thoughts or feelings people may have in social situations. 
Please read each item carefully and rate the degree to which each item is characteristic of 
you on a scale from 1 (not at all characteristic of me) to 5 (extremely characteristic of 
me). 
 
1. I worry about what people will think of me even when I know it 
doesn't make any difference. 
0     1     2     3     4     5  
 
2. I am unconcerned even if I know people are forming on 
unfavorable impression of me. 
0     1     2     3     4     5  
 
3. I am frequently afraid of other people noting my shortcomings. 0     1     2     3     4     5  
4. I rarely worry about what kind of impression I am making on 
someone. 
0     1     2     3     4     5  
5. I am afraid that others will not approve of me. 0     1     2     3     4     5 
6. I am afraid that people will find fault with me. 0     1     2     3     4     5  
7. Other people’s opinions of me do not bother me. 0     1     2     3     4     5 
8. When I am talking to someone, I worry about what they may be 
thinking about me. 
0     1     2     3     4     5  
 
9. I am usually worried about what kind of impression I make 0     1     2     3     4     5  
10. If I know someone is judging me, it has little effect on me. 0     1     2     3     4     5  
11. Sometimes I think I am too concerned with what other people 
think of me. 
0     1     2     3     4     5 















(asked by research assistant 20 seconds before the next trial) 
 
“We will now begin the first trial” 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the next trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
     




1. What is the HIGHEST level of fear you experienced at any time during the trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the trial, did you panic?   Yes  No 
 
3. At any point during the trial, did you have the urge to flee?  Yes  No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 




(asked by research assistant 20 seconds before the next trial) 
 
“We will now begin the next trial” 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the next trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
     




1. What is the HIGHEST level of fear you experienced at any time during the trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the trial, did you panic?   Yes  No 
 
3. At any point during the trial, did you have the urge to flee?  Yes  No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
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Pre-Trial 3 
(asked by research assistant 20 seconds before the next trial) 
 
“We will now begin the next trial” 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the next trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
     




1. What is the HIGHEST level of fear you experienced at any time during the trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the trial, did you panic?   Yes  No 
 
3. At any point during the trial, did you have the urge to flee?  Yes  No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
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Pre-Trial 4 
(asked by research assistant 20 seconds before the next trial) 
 
“We will now begin the next trial” 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the next trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
     




1. What is the HIGHEST level of fear you experienced at any time during the trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the trial, did you panic?   Yes  No 
 
3. At any point during the trial, did you have the urge to flee?  Yes  No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 





(asked by research assistant 20 seconds before the next trial) 
 
“We will now begin the next trial” 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the next trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
     




1. What is the HIGHEST level of fear you experienced at any time during the trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the trial, did you panic?   Yes  No 
 
3. At any point during the trial, did you have the urge to flee?  Yes  No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 




(asked by research assistant 20 seconds before the next trial) 
 
“We will now begin the next trial” 
 
1. On a scale of 0-100, what is your CURRENT level of fear? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
2. On a scale of 0-100, What is the HIGHEST level of fear you expect to experience at any time 
during the next trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
     




1. What is the HIGHEST level of fear you experienced at any time during the trial? 
 
            0 10 20 30 40 50 60 70 80 90 100 
         No fear         Extreme fear 
 
2.. At any point during the trial, did you panic?   Yes  No 
 
3. At any point during the trial, did you have the urge to flee?  Yes  No 
 
4. Please rate the intensity of the physical sensations. 
            0 10 20 30 40 50 60 70 80 90 100 
         No physical sensations         Extremely intense 
 
5. Approximately how long did the physical sensations last? _________ seconds 
 
Rate how strongly you believed the following would occur? 
  
 Death  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
        
Passing out/fainting  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all       Strongly believed 
    
 Suffocation 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Heart Attack 
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Loss of Control  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Embarrassment  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
    
 Going Crazy  
            0 10 20 30 40 50 60 70 80 90 100 
         Not at all        Strongly believed 
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        API       
Participant #:_____________________________ Date:____________________ 
 
 
For each symptom listed, please rate the greatest severity you experienced after any 
inhalation.  
(For each symptom circle one number.) 
 
                    Absent   Mild         Moderate          Severe 
Did you feel faint?    0     1  2  3 
 
Were you afraid of dying?   0     1  2  3 
 
Were you afraid in general?   0     1  2  3 
 
Did you have palpitations?   0     1  2  3 
 
Was it hard for you to breathe or to  
catch your breath?    0     1  2  3 
 
Did you have an urge to urinate?  0     1  2  3 
 
Did you have the urge to defecate?  0     1  2  3 
 
Did you feel dizzy or lightheaded?  0     1  2  3 
 
Did you feel confused at all?   0     1  2  3 
 
Did things and people seem unreal?  0     1  2  3 
 
Did you feel detached from part or all 
of your body?     0     1  2  3 
 
Was it hard for you to concentrate?  0     1  2  3 
 
Were you sweating at all?   0     1  2  3 
 
Was it difficult for you to speak?  0     1  2  3 
 
Was it be difficult for you to do your job? 
(apart from being hooked up?)   0     1  2  3 
 
Did you have any inner shakiness, twitching, 
or trembling?     0     1  2  3 
 
Did you feel nauseous or uneasy?  0     1  2  3 
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Were you afraid of going crazy?   0     1  2  3 
 
Were you afraid of losing control?  0     1  2  3 
 
Did you have any tingling or numbness?  0     1  2  3 
 
Were you experiencing any chest pain or 
discomfort?      0     1  2  3 
 
Did you have any difficulty in swallowing? 0     1  2  3 
 
Were you feeling any choking or smothering  
sensations?     0     1  2  3 
 
Were you feeling any hot or cold flashes? 0     1  2  3 
 
Was your mouth dry?    0     1  2  3 
 
Did you feel weak?    0     1  2  3 
 
Did you have a desire to flee?   0     1  2  3 
 
Did you feel depressed?    0     1  2  3 
 







The Acceptance and Action Questionnaire – Revised 
 
Below you will find a list of statements.  Please rate the truth of each statement as 
it applies to you.  Use the following scale to make your choice.   
 
 
      1----------------2-----------------3------------------4-----------------5----------------6---------------
-7     
    never           very seldom seldom  sometimes frequently       almost always         
always 




_______ 1.  I am able to take action on a problem even if I am uncertain what 
is the right thing to do.  
_______ 2.  When I feel depressed or anxious, I am unable to take care of my 
responsibilities. 
_______ 3.  I rarely worry about getting my anxieties, worries, and feelings 
under control.  
_______ 4.   I’m not afraid of my feelings.  
_______ 5.    Anxiety is bad.  
_______      6.   If I could magically remove all the painful experiences I‟ve had in my 
life, I would do so.  
_______  7.   I often catch myself daydreaming about things I’ve done and what 
I would do differently next time.  
_______  8.   When I evaluate something negatively, I usually recognize that this 
is just a reaction, not an objective fact.  
_______  9.   When I compare myself to other people, it seems that most of them 
are handling their lives better than I do. 
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Distress Tolerance Inventory 
INSTRUCTIONS: For each of the statements listed below, please select the response that 
best describes how much you agree or disagree with the statement as it applies to how 
you are normally.  
 
1. I can usually handle feelings of emotional upset quite well. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
2. I usually face emotionally upsetting situations head on. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
3. I usually follow through with tasks that are emotionally upsetting. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
4. I am able to handle feelings of emotional upset as well as most people. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
5. When faced with the choice of either facing an upsetting situation or avoiding it, I 
usually avoid it even if facing the situation is in my best interest. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
6. I’ll take fairly extreme measures to stop physical discomfort or pain. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
7. I am a real wimp when it comes to handling any kind of physical discomfort or 
pain. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
 
8. I have a high threshold for pain or other physical discomfort. 
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  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
9. I can handle quite a bit of physical pain or physical discomfort. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 
 Agree  Agree Disagree  Disagree 
 
10. Pain and other forms of physical distress do not bother me much. 
  1 2 3 4 5 6 
 Strongly Agree Slightly Slightly Disagree Strongly 






1. At this point, how logical does the intervention offered to you seem? 
1          2          3          4          5         6         7          8          9 
not at all logical             somewhat logical                      very logical 
  
2. At this point, how successful do you think this intervention will be in reducing your 
anxiety sensitivity? 
1          2          3          4          5          6          7         8          9 
not at all useful somewhat useful                       very useful 
  
3. How confident would you be in recommending this intervention to a friend with anxiety 
sensitivity? 
1          2         3         4          5          6          7          8          9 
not at all confident         somewhat confident                  very confident 
  
4. By the end of the intervention period, how much improvement in your anxiety sensitivity do 
you think will occur? 




Confidence in Full Capacity Breath 
 
1. How confident are you that the participant inhaled a complete, full capacity breath on the last 
trial? 
0%       10%     20%     30%    40%    50%    60%     70%    80%    90%     100% 
 
2. How confident are you that the participant inhaled a complete, full capacity breath on the last 
trial? 
0%       10%     20%     30%    40%    50%    60%     70%    80%    90%     100% 
 
3. How confident are you that the participant inhaled a complete, full capacity breath on the last 
trial? 
0%       10%     20%     30%    40%    50%    60%     70%    80%    90%     100% 
 
4. How confident are you that the participant inhaled a complete, full capacity breath on the last 
trial? 
0%       10%     20%     30%    40%    50%    60%     70%    80%    90%     100% 
 
5. How confident are you that the participant inhaled a complete, full capacity breath on the last 
trial? 
0%       10%     20%     30%    40%    50%    60%     70%    80%    90%     100% 
 
6. How confident are you that the participant inhaled a complete, full capacity breath on the last 
trial? 
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